Home
Search

Speakers & Presenters

Full list of speakers and presenters from the 2019 BIO International Convention.

Register

2019 Speakers & Presenters

Below is a complete list of the speakers and presenters from the 2019 BIO International Convention. Stay tuned for announcements about the 2020 BIO International Convention lineup of speakers in early 2020.

Featured Speakers
Katherine High
Katherine High , MD
PRESIDENT AND HEAD OF RESEARCH AND DEVELOPMENT, SPARK THERAPEUTICS
As president at Spark Therapeutics, Dr. Kathy High has led the development and regulatory approval of the first gene therapy for a genetic disease in…
Kenneth Frazier
Kenneth Frazier
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER, MERCK & CO, INC.
Kenneth C. Frazier is Chairman of the Board and Chief Executive Officer of Merck & Co., Inc. Under Mr. Frazier’s leadership, Merck is delivering…
George Yancopoulos
George Yancopoulos, MD, PhD
FOUNDING SCIENTIST, PRESIDENT & CHIEF SCIENTIFIC OFFICER, REGENERON
George D. Yancopoulos, MD, PhD, has built and managed Regeneron alongside Dr. Schleifer since 1989. Dr. Yancopoulos is currently President and Chief…
Katherine High
Kenneth Frazier
George Yancopoulos
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
photo
Shruti Abbato
VP OF BUSINESS DEVELOPMENT, CELDARA MEDICAL, LLC
Celdara Medical, LLC
Lebanon, New Hampshire, United States
photo
Rebecca Abbott
DIRECTOR, PUBLIC POLICY, MARCH OF DIMES
New Hope, Big Challenges: Newborn Screening in the Genetic Era
Washington, United States
photo
Thierry Abribat
Successful ventures - CEOs testimonials from bioMérieux & Alizé Pharma 3
photo
Amesh Adalja, MD
SENIOR SCHOLAR, JOHNS HOPKINS CENTER FOR HEALTH SECURITY
Platform technologies: Powering Commercial and Outbreak Development
photo
Cyrus Agarabi, MBA, PhD, PharmD, RPh
PRINCIPAL INVESTIGATOR/RESEARCH/REVIEW OFFICER/CDR, U.S. FOOD AND DRUG ADMINISTRATION
Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
photo
Dr. Ankit Agarwal, PhD
CEO, IMBED BIOSCIENCES INC.
Imbed Biosciences Inc.
Madison, Wisconsin, United States
photo
Sonalee Agarwal, Bpharm, MS, PhD
VP VALUE EVIDENCE & STRATEGY, ALNYLAM PHARMACEUTICALS
Innovative Contracting in Cell and Gene Therapies in Europe
photo
Samuel Agresta
CHIEF MEDICAL OFFICER, INFINITY PHARMACEUTICALS
What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
Cambridge, Massachusetts, United States
photo
Dr. Andrew Aherrera, MD
HEAD OF BUSINESS DEVELOPMENT, CUGENE INC.
Cugene Inc.
Waltham, Massachusetts, United States
photo
Mr. Jaeyoung Ahn, MS
HEAD OF BD, VORONOI INC.
VORONOI Inc.
INCHEON, Korea - South Korea
photo
Murray Aitken, MBA
EXECUTIVE DIRECTOR, IQVIA INSTITUTE FOR HUMAN DATA SCIENCE
Biotech’s Contribution to Innovation: Current and Future Drivers of Success
Closing the Innovation Gap in Rare Diseases: Where are we Headed?
New York, New York, United States
photo
Nsikan Akpan
DIGITAL SCIENCE PRODUCER, PBS NEWS HOUR, PBS NEWSHOUR
Falling in Love with Science: Championing Science for Everyone, Everywhere
photo
Amirah Al Idrus
EDITOR, FIERCEBIOTECH
How Could AI Help Cure Cancer in the Next Five Years?
Washington, United States
photo
Dr. Wendy Alderton, PhD
CANCER RESEARCH UK CAMBRIDGE CENTRE EARLY DETECTION PROGRAMME MANAGER, CAMBRIDGE UNIVERSITY, UK
Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
Cambridge, United Kingdom
photo
Ron Alfa, MD, PhD
SENIOR VICE PRESIDENT, TRANSLATIONAL DISCOVERY, RECURSION PHARMACEUTICALS
Power of AI/ML in Biopharma Drug Discovery and Development
photo
Jim Alferman
ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, SEKISUI
Sekisui
St. Louis, Missouri, United States
photo
Dr. Khatija Ali
CEO, BIOSAPIEN INC
BioSapien Inc.
Brooklyn, New York, United States
photo
Debbie Allen
SENIOR VICE PRESIDENT BUSINESS DEVELOPMENT, ARGEN-X
Advanced Business Development Day 2
photo
Brandon Allgood
CTO, NUMERATE
The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine
San Francisco, California, United States
photo
Niva Almaula
CHIEF BUSINESS OFFICER, ACTINIUM PHARMACEUTICALS, INC.
Actinium Pharmaceuticals, Inc.
photo
Cambria Alpha-Cobb
PATENT AGENT, MOMENTA PHARMACEUTICALS
Don’t Be Barred by the On-Sale Bar: Helsinn and Other Case Updates
Boston, Massachusetts, United States
photo
Dr. Michael Altorfer
CEO, SWISS BIOTECH ASSOCIATION
Switzerland - Global Innovation Hub
Zürich, Switzerland
photo
Prof. Nathan Alves
PRESIDENT AND CEO, INDIANA LYSIS TECHNOLOGIES
Indiana Lysis Technologies
Indianapolis, Indiana, United States
photo
David Anderson
CNS RESEARCH LEAD, SPARK THERAPEUTICS
Complex CNS diseases: The Next Frontier in AAV Gene Therapy
photo
Mr. Django Andrews, JD
DIRECTOR, SR. PATENT COUNSEL, SAREPTA THERAPEUTICS, INC.
Ready to Launch? IP Strategies for Emerging Pharma and Biotech Companies Navigating Regulatory Approval
Cambridge, Massachusetts, United States
photo
Mark Angelicola
SENIOR MANAGER, CLINICAL MANAGEMENT, OTSUKA PHARMACEUTICAL COMPANIES (U.S.)
Disruptive Innovation in Clinical Trials: Tools to Accelerate Recruitment
photo
Mr. William Annett, MBA
CEO, ONCOCYTE CORPORATION
OncoCyte Corporation
Alameda, California, United States
photo
Paula Annunziato
VP, CLINICAL RESEARCH, GCD, VACCINES, MERCK & CO., INC.
The State of the Vaccine Industry: Stimulating Sustainable Growth
photo
Christopher Anselmo
MARKET INTELLIGENCE MANAGER, MUSCULAR DYSTROPHY ASSOCIATION
Understanding the Voices of Patients: Unique Perspectives on Healthcare
Westbrook, Connecticut, United States
photo
Anjan Aralihalli
CHIEF BUSINESS OFFICER; VENTURE PARTNER, GLYPHARMA THERAPEUTIC; CTI LIFE SCIENCES FUND II
Business Development Fundamentals Day 3
photo
Simon Arkell
PRESIDENT, DEEP LENS
Deep Lens
photo
John Armando
MANAGER, GLOBAL REGULATORY AFFAIRS CMC, BIOGEN
Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
photo
Dr. Jon Arnason, MD
HARVARD MEDICAL FACULTY PHYSICIAN, HEMATOLOGY/ONCOLOGY, BETH ISRAEL DEACONESS MEDICAL CENTER
Valuing a Transformative Cancer Therapy: Perspectives on CAR T from Across the Healthcare Industry
photo
Phyllis Arthur
VICE PRESIDENT, INFECTIOUS DISEASES AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Strategy and Policy Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Collaboration
photo
Fredrik Aslund
TEAM MANAGER, EPO
Pitfalls for US Applicants When Filing Patent Applications at the EPO
photo
Anil Asnani
VP, LABCORP
How Can Biopharma Divest to Innovate?
Burlington, North Carolina, United States
photo
Jessica Atkinson
VICE PRESIDENT, CORPORATE AND BUSINESS DEVELOPMENT , FOUNDATION MEDICINE
The Changing Landscape in Pharma/Diagnostic Partnerships
Cambridge, Massachusetts, United States
photo
Dr. Hartley Atkinson
CEO, AFT PHARMACEUTICALS
AFT Pharmaceuticals Ltd
Takapuna, New Zealand
photo
Jim Audia
EXECUTIVE DIRECTOR, CHICAGO BIOMEDICAL CONSORTIUM
Derisking Academic Science: The Unmet Need
photo
Christopher Austin, MD
DIRECTOR, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS) , NATIONAL INSTITUTES OF HEALTH
New Models for Translational Research Collaboration
NIH as a Catalyst: Developing the Next Generation of Pain and Addictions Treatments
photo
Mr. John Babitt
PARTNER, EY
The New World of Life Sciences M&A Valuation: Strategies to Adapt and Thrive
New York, New York, United States
photo
Gerri Baer
MEDICAL OFFICER, NEONATOLOGY TEAM LEADER, U.S. FOOD AND DRUG ADMINISTRATION
Building a Brighter Future for Children: How Will Large Pediatric Trial Networks Help Deliver Safe, Effective Medicines?
photo
Ms. Blanca Baez
SVP, GLOBAL HEALTH OF PHARMA & BIOTECH, MOLECULAR HEALTH
Molecular Health
Heidelberg, Germany
photo
Richard Bagger
EXECUTIVE VICE PRESIDENT, CORPORATE AFFAIRS AND MARKET ACCESS, CELGENE CORPORATION
Valuing a Transformative Cancer Therapy: Perspectives on CAR T from Across the Healthcare Industry
photo
Mr. David Baker, MBA
PRESIDENT & CEO, VALLON PHARMACEUTICALS
Vallon Pharmaceuticals
Philadelphia, Pennsylvania, United States
photo
Dr. Annette Bakker
PRESIDENT, CHILDREN’S TUMOR FOUNDATION
Innovative Collaborations to Speed Science to Patients
Building a Brighter Future for Children: How Will Large Pediatric Trial Networks Help Deliver Safe, Effective Medicines?
New York, New York, United States
photo
Daniel Barber
CHIEF STRATEGY & DEVELOPMENT OFFICER, AQUESTIVE THERAPEUTICS
How to Ensure Access Doesn’t Get in the Way of Good Science
photo
Dr. Christopher Barden
CEO, TREVENTIS
Treventis Corporation
Toronto, Ontario, Canada
photo
Alan Bash
SENIOR VICE PRESIDENT, HEAD OF COMMERCIAL FOR IMMUNOSCIENCE, CARDIOVASCULAR AND FIBROSIS, BRISTOL-MYERS SQUIBB
Oncology “First Launch” and Partnering
photo
Eran Bashan
CEO, HYGIEIA
Machine Learning and Artificial Intelligence: Realizing Precision Medicine One Patient at a Time
Hygieia, Inc.
Ann Arbor, Michigan, United States
photo
Alex Bastian
VICE PRESIDENT OF MARKET ACCESS, GALAPAGOS NV
The Value of Progression-Free Survival
photo
Mr. Steve Bates
CEO, BIOINDUSTRY ASSOCIATION
Brexit and the Impact on the Biotechnology Industry
London, United Kingdom
photo
Gaurav Batra, PhD
ASSISTANT PROFESSOR, TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE, TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE, INDIA
Diagnostics for Infectious Diseases
photo
Roy Baynes, BCH, MB, MD, Med, PhD
SENIOR VICE PRESIDENT, GLOBAL CLINICAL DEVELOPMENT & CHIEF MEDICAL OFFICER, MERCK RESEARCH LABORATORIES
What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
Rahway, New Jersey, United States
photo
Kate Beale
ASSOCIATE VICE PRESIDENT FOR INTERNATIONAL ADVOCACY, PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, PHRMA
India's Contribution in Global Biotech R&D
photo
Edwin Beale
VP BUSINESS DEVELOPMENT, MASTHERCELL GLOBAL
Brexit and the Impact on the Biotechnology Industry
photo
Andrew Beck
CO-FOUNDER AND CEO, PATH AI, INC.
Power of AI/ML in Biopharma Drug Discovery and Development
Boston, Massachusetts, United States
photo
Jacob Becraft
CO-FOUNDER, STRAND THERAPEUTICS
Strand Therapeutics
Cambridge, Massachusetts, United States
photo
Dr. Alexander Bedenkov
MEDICAL AFFAIRS VICE-PRESIDENT, INTERNATIONAL REGION, ASTRAZENECA
Expanding Early Stage Research Through Global Partnerships
Cambridge, United Kingdom
photo
Dr. Manolo Beelke
SVP - SCIENTIFIC AND MEDICAL AFFAIRS, NAVITAS LIFE SCIENCES
Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies
photo
Andrew Bellinger
CSO, LYNDRA INC
Lyndra Inc.
Watertown, Massachusetts, United States
photo
Deanna Belsky, PhD
ASSOCIATE, DOLBY FAMILY VENTURES
Family Offices, Foundations, Impact Investors, and Venture Accelerators: How They Play the Game
photo
Dr. Jeffrey Bemis
DIRECTOR OF CLINICAL STUDIES, LITRON LABORATORIES
Litron Laboratories
Rochester, New York, United States
photo
Ms. Cynthia Bens
SENIOR VICE PRESIDENT, PUBLIC POLICY, PERSONALIZED MEDICINE COALITION
Coverage for Advanced Diagnostics and the Impact on Patient Access to Personalized Medicine
Washington, District Of Columbia  , United States
photo
Andrew Bentham
PARTNER, PATENT ATTORNEY, J A KEMP
Don’t Be Barred by the On-Sale Bar: Helsinn and Other Case Updates
photo
Lisa Benz
STRATEGIC CLIENT ENGAGEMENT DIRECTOR, COPYRIGHT CLEARANCE CENTER
Copyright Clearance Center
photo
Dan Berglund
PRESIDENT AND CEO, STATE SCIENCE & TECHNOLOGY INSTITUTE
Technology-Based Economic Development: Evolving Models, Strategies and Finance Approaches
Westerville, Ohio, United States
photo
Chris Bergstrom
DIGITAL THERAPY LEAD, BOSTON CONSULTING GROUP; BCG
DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy
photo
Fabian Berkemeier
DIRECTOR VALUE AND ACCESS STRATEGY, IGES INSTITUTE (GERMANY)
Referencing European Prices for Medicare Part B Drugs
Innovative Contracting in Cell and Gene Therapies in Europe
photo
Joshua Berlin
EXECUTIVE DIRECTOR, BIOCENTURY
China Summit Segment I: Opening Remarks / Key Regulatory and Policy Trends in Biopharmaceutical Innovation
photo
Kevin Bernier
DIRECTOR OF ADVOCACY RELATIONS , BAYER
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned from a Novel Pilot Program
Whippany, New Jersey, United States
photo
Dr. Donald Berry
PROFESSOR, UNIVERSITY OF TEXAS
Re-Imagining Clinical Trials: Ideas and Early Feedback on New Trial Designs
Houston, Texas, United States
photo
Doug Berven
V.P. OF CORPORATE AFFAIRS, POET
Is Hand-Me-Down Separation Technology Holding Back the Bioeconomy?
London, United Kingdom
photo
Dr. Marc Bessler
PROFESSOR OF SURGERY / CEO, COLUMBIA UNIVERSITY / ENDOBETES
EndObetes
New York, New York, United States
photo
Mrs. Leonie Best
CBO, MADAM THERAPEUTICS
Madam Therapeutics
Woerdense Verlaat, Netherlands
photo
Maina Bhaman
PARTNER, CAPITAL FUNDS, SOFINNOVA
Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future
photo
Kailash Bhol, PhD
DIRECTOR, PRECLINICAL DEVELOPMENT, ASTELLAS INSTITUTE OF REGENERATIVE MEDICINE
Opportunities and Challenges of Cell and Gene Therapy Development
photo
Florence Bietrix
OPERATIONS MANAGER, EATRIS
Novel Approaches to Improve Reproducibility in Academia-Industry Collaborations
Netherlands
photo
Gwendolyn Binder
EXECUTIVE VICE PRESIDENT, SCIENCE & TECHNOLOGY, CABALETTA BIO
The Science of Shattering the Lab’s Glass Ceiling
photo
Mr. Paul Biondi, MBA
HEAD OF STRATEGY AND BUSINESS DEVELOPMENT , BRISTOL-MYERS SQUIBB
Bristol-Myers Squibb
Deals that Move You: Tips and Tricks for Getting Results
Princeton, New Jersey, United States
photo
Michael Biron
CEO, ALTIS BIOSYSTEMS, INC.
Altis Biosystems, Inc.
Chapel Hill, North Carolina, United States
photo
Mr. Darcy Birse
SENIOR VICE PRESIDENT, GLOBAL SALES, LONZA
Lonza Pharma & Biotech (SIX Stock Exchange:LONN)
Portsmouth, New Hampshire, United States
photo
John Bishai
MANAGING DIRECTOR, HEALTHCARE INVESTMENT BANKING, WELLS FARGO
Dealmakers' Intentions: 2019 Market Outlook
photo
Fritz Bittenbender
SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, GENENTECH
The Changing Global Face of Biotechnology: Opportunities and Challenges for Healthcare Systems
photo
Brian Bloomquist, PhD
DIABETES EXTERNAL INNOVATION, ELI LILLY AND COMPANY
Addressing Unmet Need in Diabetes/Obesity
photo
Dr. Roberto Bobadilla
CEO, CELLS FOR CELLS
Cells for Cells
Santiago, Chile
photo
Jeffrey Bockman, PhD
EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Immuno-Oncology: Taking Immunotherapies to the Next Level
New York, New York, United States
photo
Raza Bokhari, MD
CO-CHAIRMAN AND INTERIM CEO, FSD PHARMA
Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots
photo
Dr. Chris Boles, PhD
CSO, SAGE SCIENCE
Sage Science, Inc
Bevery, Massachusetts, United States
photo
Crystal Booth
REGIONAL MANAGER, PSC BIOTECH
PSC Biotech
Ponoma, California, United States
photo
Luciana Borio, MD
VICE PRESIDENT, TECHNICAL STAFF, IN-Q-TEL
The Future of Influenza Vaccines
photo
Katrine Bosley
CHAIR, EMERGING COMPANIES SECTION, BIO
Fireside Chat with Margaret (Peggy) Hamburg, MD, Foreign Secretary, National Academy of Medicine; Chairman of the Board, American Association for the Advancement of Science
photo
Vanessa Boulanger
DIRECTOR OF RESEARCH, NATIONAL ORGANIZATION FOR RARE DISORDERS
Telling the Story: How Collaborative Research Models Address Knowledge Gaps and Bring Transparency to the Rare Disease Patient Journey
Danbury, Connecticut, United States
photo
Ms. Carrie Bourdow
PRESIDENT & CEO, TREVENA, INC.
Trevena, Inc
Wayne, Pennsylvania, United States
photo
John Boyce
MANAGING DIRECTOR AND CO-FOUNDER, TIGERGENE LLC
The Secret Recipe to Maximizing Deals in Precision Medicine
Waltham, Massachusetts, United States
photo
Mr. John Boyle, MA
PRESIDENT & CEO, IMMUNE DEFICIENCY FOUNDATION
Immune Deficiency Foundation
Towson, Maryland, United States
photo
Nick Boyle, MBA, PhD
VICE PRESIDENT, CORPORATE STRATEGY AND BUSINESS DEVELOPMENT, TOCAGEN
Gene Therapy 2.0: No Longer Science Fiction
San Diego, California, United States
photo
Mr. Thomas Bradshaw
CEO, NEURONASAL
Neuronasal
Wexford, Pennsylvania, United States
photo
Christian Braemer
CEO/CO-FOUNDER, BENEFUNDER
Family Offices, Foundations, Impact Investors, and Venture Accelerators: How They Play the Game
photo
Ilana Brand
VICE PRESIDENT, BUSINESS DEVELOPMENT, COOLEY
DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy
photo
Kim Brandt
PRINCIPAL DEPUTY ADMINISTRATOR FOR OPERATIONS, CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS)
Addressing Barriers to Coverage and Access for Pain and Addiction Treatment: Where are We Now?
photo
Ms. Susan Bratton
CEO AND FOUNDER, SAVOR HEALTH
Savor Health
New York, New York, United States
photo
Dr. Kathrin Brenker
CEO, OPTO BIOLABS
Opto Biolabs
Freiburg, Germany
photo
Aoife Brennan, MB
PRESIDENT & CEO, CMO, SYNLOGIC
New Models for Translational Research Collaboration
photo
Dr. Rick Bright
DEPUTY ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, DIRECTOR OF BIOMEDICAL ADVANCES RESEARCH AND DEVELOPMENT AUTHORITY, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHA)
Sustainable Financing – Are We Building Half a Bridge?
photo
Mrs. Jennifer Bright
EXECUTIVE DIRECTOR , INNOVATION AND VALUE INITIATIVE
The Forecast for Value – The Role of Value Assessment Frameworks
Alexandria , Virginia, United States
photo
Kathleen Broglio
ASSISTANT PROFESSOR OF MEDICINE, GEISEL SCHOOL OF MEDICINE AT DARTMOUTH
Addressing Barriers to Coverage and Access for Pain and Addiction Treatment: Where are We Now?
photo
Brian Bronk, PhD
HEAD OF BUSINESS DEVELOPMENT, RARE DISEASES & RARE BLOOD DISORDERS, GLOBAL BD&L, SANOFI
Swinging for the Fences: The Dichotomy in Rare Disease Investment and Development
photo
Steve Brozak
PRESIDENT AND FOUNDER, SBB SECURITIES
Powered by BARDA – Innovative Government Models
photo
Dr. Claudine Bruck
CHIEF EXECUTIVE OFFICER, PROLIFAGEN LLC
Prolifagen
Villanova, Pennsylvania, United States
photo
Carsten Brunn
PRESIDENT AND CEO, SELECTA BIOSCIENCES, INC.
Review of Regulatory-Based Policy Incentives: What's It Worth?
photo
Dr. Wilson Bryan
DIRECTOR, OFFICE OF TISSUES AND ADVANCED THERAPIES (OTAT), CBER, FDA
Update on the Evolving Global Gene Therapy Regulatory Policy Landscape
Silver Spring, Maryland, United States
photo
Mr. Douglas Bryce
JOINT PROGRAM EXECUTIVE OFFICER, JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE (JPEO-CBRND)
Strategy and Policy Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Collaboration
photo
Dr. Paul Bryson, PhD
DIRECTOR, TCRCURE BIOPHARMA
TCRCure Biopharma
Los Angeles, California, United States
photo
Jennifer Buell, PhD
CHIEF OPERATING OFFICER, AGENUS, INC.
Immuno-Oncology: Taking Immunotherapies to the Next Level
photo
Eve Bukowski
VICE PRESIDENT, PATIENT ADVOCACY, EDUCATION & OUTREACH, CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA)
Understanding the Voices of Patients: Unique Perspectives on Healthcare
photo
Dr. Christopher J. Burns, PhD
PRESIDENT AND CEO, VENATORX PHARMACEUTICALS
VenatoRx Pharmaceuticals, Inc.
Malvern, Pennsylvania, United States
photo
Howard "Skip" Burris, MD
PRESIDENT, ASCO
What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
photo
Mr. Matthew Cabrey
EXECUTIVE DIRECTOR, SELECT GREATER PHILADELPHIA
Greater Philadelphia & the Navy Yard
Philadelphia, Pennsylvania, United States
photo
Maarten Camps
SECRETARY GENERAL , MINISTRY OF ECONOMIC AFFAIR AND CLIMATE POLICY
Spurring Biotech Innovation in Global Markets
Netherlands
photo
James Canterbury
PRINCIPAL, EY
Bitcoin Your Data! From Trusted Pharma Silos to Trustless Community-Owned Blockchain-Based Precision Medicine Data Trials
photo
Susan Cantrell, CAE, RPh
CHIEF EXECUTIVE OFFICER, ACADEMY OF MANAGED CARE PHARMACY (AMCP)
Finding the Nexus Between Patient and Payer Needs in Rare Disease
photo
Dr. William Capra
GLOBAL HEAD OF REAL WORLD DATA, ONCOLOGY, GENENTECH
Considerations for Study Designs Incorporating External Data Sources to Augment or Generate Control Arm
South San Francisco, California, United States
photo
Tanisha Carino
EXECUTIVE DIRECTOR, FASTERCURES, MILKEN INSTITUTE
Innovative Collaborations to Speed Science to Patients
Washington, United States
photo
Governor John Carney
, STATE OF DELAWARE
BIO 2019 Governor’s Fireside Chat
photo
Dr. Ambrose Carrejo
NATIONAL PHARMACEUTICAL CONTRACTING LEADER, FORMER KAISER PERMANENTE
New Approaches to Reimbursement for Gene Therapy: What Can We Learn From Models Currently in Practice?
United States
photo
Dr. Paolo Cassano, MD, PhD
CO-FOUNDER, CHIEF RESEARCHER & CHAIR OF SCIENTIFIC ADVISORY BOARD, NIRAXX THERAPEUTICS
The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies
photo
Mr. Kenneth Cawkell
CEO , NEURODYN COGNITION INC
Neurodyn Cognition Inc.
Vancouver , British Columbia, Canada
photo
Dr. Gabriela Cezar, PhD
CEO, PANAREA PARTNERS INC.
The Science of Cannabis for Healthcare Innovation Around the World: Key Scientific, Regulatory, and Commercial Developments
Uruguay - Global Innovation Hub
New York, New York, United States
photo
Meghana Chalasani
SR RESEARCH ANALYST, FDA
Patient-Focused Drug Development: From Concept to Reality
photo
Mr. Michael Chan
SENIOR VICE PRESIDENT , HONG KONG EXCHANGES AND CLEARING LIMITED (HKEX)
China Summit Segment II: Cross-Border Outlook – Access to Capital and Partnering Strategies for the China Market
photo
JianQing Chang
VICE PRESIDENT, DRUG REGULATORY POLICY, TIGERMED
China Summit Segment I: Opening Remarks / Key Regulatory and Policy Trends in Biopharmaceutical Innovation
photo
Sobin Chang
CEO, AQUAVIT PHARMACEUTICALS INC
Aquavit Pharmaceuticals Inc
New York, New York, United States
photo
Dr. Bob Chapman
, AUXLY CANNABIS GROUP
The Science of Cannabis for Healthcare Innovation Around the World: Key Scientific, Regulatory, and Commercial Developments
photo
Gary Charbonneau
SENIOR VICE PRESIDENT OF REGULATORY AFFAIRS, SAREPTA
Genome Editing and Regulatory Harmonization: Progress and Challenges
photo
Dr. Mylea Charvat
CEO & FOUNDER, SAVONIX
Beyond Dementia: The REALLY Big Opportunities in Neuroscience
San Francisco, California, United States
photo
Dr. Kleem Chaudhary, PhD
HEAD BD&L MS, AD, OPN, PLATFORMS, BIOGEN
How Early is Too Early? Valuing and De-Risking Preclinical Opportunities
Cambridge, Massachusetts, United States
photo
Dr. Guljit Chaudhri, MD
CHIEF, MANAGING DIRECTOR, INNONATION, ABLE, BIOINNOVAT
Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies
photo
Dr. Anil Chauhan, MBA, PhD
SENIOR ADVISER, ABLE
India Bioconomy - Global Innovation Hub
Bangalore, India
photo
Dr. Yuan Chen
CEO, SUMO BIOSCIENCES, INC.
SUMO Biosciences, Inc.
Pasadena, California, United States
photo
Dr. Ruby Chen-Tsai
CSO, APPLIED STEMCELL
Applied StemCell Inc.
Milpitas, California, United States
photo
Mantej (Nimi) Chhina
DIRECTOR, REGULATORY POLICY & FDA ENGAGEMENT, BIOMARIN PHARMACEUTICAL INC.
Update on the Evolving Global Gene Therapy Regulatory Policy Landscape
photo
Constantine Chinoporos
CHIEF BUSINESS OFFICER, BOSTON PHARMACEUTICALS
Boston Pharmaceuticals
Dealmakers' Intentions: 2019 Market Outlook
Cambridge, Massachusetts, United States
photo
Ms. Lorraine Chiroiu, BA, MBA
CEO, AUSBIOTECH
The Changing Global Face of Biotechnology: Opportunities and Challenges for Healthcare Systems
Australia - Global Innovation Hub
Melbourne, Australia
photo
Tom Chittenden
VICE PRESIDENT, STATISTICAL SCIENCES FOUNDING DIRECTOR, , WUXI NEXTCODE GENOMICS
The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine
Cambridge, Massachusetts, United States
photo
David Cho
LEAD SCIENTIFIC REVIEWER, CENTER, FOOD & DRUG AMINISTRATION
Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
photo
Robert Chu
CEO & FOUNDER, EMBLEEMA
Embleema
New York, New York, United States
photo
Jeannette Chu, BA
MANAGING DIRECTOR, PRICEWATERHOUSECOOPER
China Summit Segment I: Opening Remarks / Key Regulatory and Policy Trends in Biopharmaceutical Innovation
photo
Dr. Woei-Jer Chuang, PhD
DIRECTOR GENERAL, DEPARTMENT OF LIFE SCIENCES, MINISTRY OF SCIENCE AND TECHNOLOGY, TAIWAN
There is $200B in Global Investment in the Biopharmaceutical Sector Each Year. Who’s Getting It and Why?
Taipei, Taiwan
photo
Prof. Jongsik Chun
CEO, CHUNLAB, INC.
ChunLab, Inc.
Seoul, Korea - South Korea
photo
Dr. Michael Ciesielski, MS, PhD
CEO, MIMIVAX, LLC
MimiVax, LLC
Buffalo, New York, United States
photo
Dr. Dan Close
CHIEF SCIENTIFIC OFFICER, 490 BIOTECH
490 BioTech
Knoxville, Tennessee, United States
photo
Brent Clough
CHIEF EXECUTIVE OFFICER, TRIO HEALTH
Telling the Story: How Collaborative Research Models Address Knowledge Gaps and Bring Transparency to the Rare Disease Patient Journey
La Jolla, California, United States
photo
Dr. Erick Co
CEO, FORMOSA PHARMACEUTICALS, INC
Formosa Pharmaceuticals
Taoyuan City, Taiwan
photo
Megan Coder, PharmD
EXECUTIVE DIRECTOR, DIGITAL THERAPEUTICS ALLIANCE
DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy
Machine Learning and Artificial Intelligence: Realizing Precision Medicine One Patient at a Time
Arlington, Virginia, United States
photo
CAPT Joseph Cohn
CHIEF, RESEARCH PROGRAM ADMINISTRATION DIVISION, J9 RESEARCH AND DEVELOPMENT DIRECTORATE, DEFENSE HEALTH AGENCY (DHA)
Technology Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Innovation
photo
Mr. George Colberg Jr.
CEO CO-FOUNDER, KALOS THERAPEUTICS INC
Kalos Therapeutics Inc
Phoenix, Arizona, United States
photo
Mr. Charles Collins-Chase, JD
PARTNER, FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
Ready to Launch? IP Strategies for Emerging Pharma and Biotech Companies Navigating Regulatory Approval
Washington, United States
photo
Dr. Grace Colon, BS, PhD
CEO, INCARDA THERAPEUTICS
Non-traditional CEOs and Founders – How to Win in a Traditional World
Addressing Unmet Need in Cardiovascular Disease
Newark, California, United States
photo
Dr. John Colson, PhD
DIRECTOR OF OPERATIONS, CLOSTRABIO, INC
ClostraBio, Inc
Chicago, Illinois, United States
photo
Roger Connor
PRESIDENT, GSK VACCINES, GLAXOSMITHKLINE
The State of the Vaccine Industry: Stimulating Sustainable Growth
photo
Hon. Roger Cook
DEPUTY PREMIER; MINISTER FOR HEALTH, GOVERNMENT OF WESTERN AUSTRALIA
Western Australia - Global Innovation Hub
East Perth WA, Australia
photo
Brett Cook
SENIOR ASSOCIATE, F-PRIME CAPITAL
Investors Corner: Perspectives and Predictions for 2019 and Beyond
photo
Christopher Coons
U.S. SENATOR FOR DELAWARE
IP Track Opening Plenary with Senator Christopher Coons (D.-Del)
photo
Mark J. Cooper
PRINCIPAL, FABER DAEUFER & ITRATO PC
Business Development Fundamentals Day 2
Business Development Fundamentals Day 3
photo
Andrea Coravos
CEO/CO-FOUNDER, ELEKTRA LABS
Machine Learning and Artificial Intelligence: Realizing Precision Medicine One Patient at a Time
Boston, Massachusetts, United States
photo
Lily Cortese
DIRECTOR, TRANSACTIONS, JOHNSON & JOHNSON
Changing the Game: Breaking Down Barriers and Building Up the Next Generation
photo
Gregory P. Cosgrove
CHIEF MEDICAL OFFICER, PULMONARY FIBROSIS FOUNDATION
Rare Diseases: Maximizing Natural History in Clinical Development
photo
Dr. Nathan Coussens, PhD
SENIOR RESEARCH SCIENTIST, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NATIONAL INSTITUTES OF HEALTH
Novel Approaches to Improve Reproducibility in Academia-Industry Collaborations
Rockville, Maryland, United States
photo
Ms. Kathleen Coviello
VICE PRESIDENT, TECHNOLOGY AND LIFE SCIENCES INVESTMENTS, NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY
New Jersey - Global Innovation Hub
Trenton, New Jersey, United States
photo
Manon Cox, MBA
CEO, MATRIVAX
Sustainable Financing – Are We Building Half a Bridge?
photo
Jennifer Cozzone, MSc
GLOBAL PERSONALISED HEALTHCARE LEAD, SPECIALTY CARE, ROCHE
Precision Medicine Beyond Oncology
photo
Ryan Cross, MS
ASSISTANT EDITOR, CHEMICAL & ENGINEERING NEWS
Gene Therapy 2.0: No Longer Science Fiction
Boston, Massachusetts, United States
photo
Ryan Cross
ASSISTANT EDITOR, CHEMICAL & ENGINEERING NEWS
Harnessing the Potential of Exosomes
Cambridge, Massachusetts, United States
photo
Lowry Curley
CEO, AXOSIM, INC
Humans-in-a-Dish: Hope or Hype?
New Orleans, Louisiana, United States
photo
Colleen Cutcliffe
CEO AND CO-FOUNDER, WHOLE BIOME INC
The Business of Microbiomes: Translating Research into Evidence-Based Clinical Products
photo
Tracy Cutler
SENIOR REGULATORY HEALTH PR, U.S. FOOD AND DRUG ADMINISTRATION
Rare Diseases: Maximizing Natural History in Clinical Development
photo
Gerald Dal Pan, MD, MHS
DIRECTOR OF THE OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY, CENTER FOR DRUG EVALUATION AND RESEARCH, U.S. FOOD & DRUG ADMINISTRATION
Opioids: Changing the paradigm of treating pain and addiction - one year later
photo
Barbara Dalton
VICE PRESIDENT, WORLDWIDE BUSINESS DEVELOPMENT, PFIZER INC.
What’s Next: The Landscape of Innovation in 2019 and Beyond
photo
Dr. Gregory Daniel , MPH, PhD, RPh
DEPUTY DIRECTOR FOR POLICY , DUKE-MARGOLIS CENTER FOR HEALTH POLICY
It Starts with One Step: Piloting New Payment and Reimbursement Models for Novel Antibiotics in the US
The Path Forward for Value-Based Payment for Transformative Therapies
Washington, United States
photo
Roger Dansey
CHIEF MEDICAL OFFICER, SEATTLE GENETICS
The Value of Progression-Free Survival
photo
Mark Dant
VOLUNTEER EXECUTIVE DIRECTOR & FOUNDER, RYAN FOUNDATION
Scientific Advances in Genome Editing: Where are we Today?
photo
Barry Datlof
Successful ventures - CEOs testimonials from bioMérieux & Alizé Pharma 3
photo
Mr. Indra Datta
PRESIDENT, NANOCLIQ LLC
NanoCliq LLC
Kennesaw, Georgia, United States
photo
Dr. Anirban Datta
SENIOR DIRECTOR OF DISCOVERY BIOLOGY, VERSEON
Verseon Corporation (AIM:VERS)
Fremont, California, United States
photo
Eric David , JD, MD
CHIEF EXECUTIVE OFFICER, ASPA THERAPEUTICS
Gene Therapy 2.0: No Longer Science Fiction
Palo Alto, California, United States
photo
Christian Davis
INTERNATIONAL TRADE PARTNER, AKIN GROUP
China Summit Segment I: Opening Remarks / Key Regulatory and Policy Trends in Biopharmaceutical Innovation
photo
Khrystal Davis
RARE DISEASE PARENT, CAREGIVER, PATIENT ADVOCATE, AUTHOR & FOUNDER, TEXAS RARE ALLIANCE
Finding the Nexus Between Patient and Payer Needs in Rare Disease
Crave Coeur, Missouri, United States
photo
Marianne De Backer, MBA, MSc, PhD
VP, GLOBAL M&A OPERATIONS AND DIVESTITURES (PHARMACEUTICALS GROUP), GLOBAL INFECTIOUS DISEASES & VACCINES BUSINESS DEVELOPMENT, JOHNSON & JOHNSON INNOVATION
It Starts with One Health: A Guide to Translational Science from Research to Investment
How Can Biopharma Divest to Innovate?
photo
Dr. Carmela De Luca
PARTNER, BERESKIN & PARR LLP
Patentable Subject Matter Around the World: Life Science Inventions in Canada, Europe, China, Australia and New Zealand
Montreal, Quebec, Canada
photo
Andrea de Souza
SENIOR DIRECTOR, ELI LILLY AND COMPANY
The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine
Indianapolis, Indiana, United States
photo
Mr. Anthony DeBoer
DIRECTOR, BUSINESS DEVELOPMENT, SYNAFFIX BV
Synaffix BV
Amsterdam, Netherlands
photo
Laura DeFrancesco, PhD
SENIOR EDITOR, NATURE BIOTECHNOLOGY
Scientific Advances in Genome Editing: Where are we Today?
photo
Aurélie Deleforge, MSc, Mphil
PRECISION MEDICINE PRACTICE LEAD, BIONEST PARTNERS
Precision Medicine Beyond Oncology
photo
Dr. Marta Delsignore, PhD, JD
PARTNER, GOODWIN
The Science of Cannabis for Healthcare Innovation Around the World: Key Scientific, Regulatory, and Commercial Developments
New York, New York, United States
photo
Mr. John Demaree
CHIEF COMMERCIAL OFFICER, G1 THERAPEUTICS
Oncology “First Launch” and Partnering
Research Triangle Park, North Carolina, United States
photo
Ms. Laura Deming
FOUNDER, MANAGING PARTNER, THE LONGEVITY VC
Anti-Aging Therapies: Taking Action to Increase the Human Healthspan
San Francisco, California, United States
photo
Robert Dempster
DIRECTOR, SCRIPT IP
Pitfalls for US Applicants When Filing Patent Applications at the EPO
photo
Kathleen A. Denis
CLP-FOUNDING DIRECTOR, OFFICE OF TECHNOLOGY TRANSFER
Business Development Fundamentals Day 3
photo
Jennifer Dent
PRESIDENT, BIO VENTURES FOR GLOBAL HEALTH (BVGH)
Ensuring Access to Vital Medicines While Maintaining Sustainable Markets: A Global Balancing Act for the Pharmaceutical Industry
photo
Susan Dentzer
VISITING FELLOW, ROBERT J. MARGOLIS CENTER FOR HEALTH POLICY, DUKE UNIVERSITY
BIO 2019 Governor’s Fireside Chat
photo
Mr. Chris DeRespino
EXECUTIVE DIRECTOR, BUSINESS DEVELOPMENT, AMGEN INC.
Amgen Inc.
So San Francisco, California, United States
photo
Mike Derkacz
PRESIDENT & CEO, BRAEBURN
NIH as a Catalyst: Developing the Next Generation of Pain and Addictions Treatments
photo
Mr. Pier DeRoo, JD
ATTORNEY, FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
Ready to Launch? IP Strategies for Emerging Pharma and Biotech Companies Navigating Regulatory Approval
Washington, United States
photo
Dr. Nazneen Dewji
CEO, CENNA BIOSCIENCES INC.
Cenna Biosciences Inc.
La Jolla, California, United States
photo
Adam Dickers, MD, PhD
PROFESSOR, SR. VP AND CHAIR, ENTERPRISE RADIATION ONCOLOGY, JEFFERSON UNIVERSITY
Digital Integration in Healthcare: Real-World Scenarios from Leading Healthcare Institutions & Fireside Chat with Carina Edwards, CEO, Quil
photo
Q. Todd Dickinson
SENIOR PARTNER , POLSINELLI PC
Innovators and Biosimilars: Strategies for Having Both Under the Same Roof
photo
Joseph S. Dillon
PRESIDENT, DILLON CAPITAL STRATEGIES
Advanced Business Development Day 1
photo
Hildy Dillon, MPH
SENIOR VICE PRESIDENT, EDUCATION AND SUPPORT PROGRAMS, CANCER SUPPORT COMMUNITY
The Value of Progression-Free Survival
photo
Susan B. Dillon
PRESIDENT & CEO, ARO BIOTHERAPEUTICS
The Science of Shattering the Lab’s Glass Ceiling
Philadelphia, Pennsylvania, United States
photo
Jamie Dimon
CHAIRMAN & CEO, JPMORGAN CHASE & CO
Keynote: Jamie Dimon
photo
Anil Diwan, PhD
PRESIDENT & EXEC. CHAIRMAN, NANOVIRICIDES, INC.
NanoViricides, Inc.
Shelton, Connecticut, United States
photo
Mr. David Dodd
PRESIDENT & CEO, GEOVAX LABS, INC.
GeoVax Labs, Inc.
Smyrna, Georgia, United States
photo
Douglas Doerfler
PRESIDENT & CEO, MAXCYTE, INC.
MaxCyte, Inc.
Gaithersburg, Maryland, United States
photo
Patsy Doerr
GLOBAL HEAD, CORPORATE RESPONSIBILITY & INCLUSION, THOMSON REUTERS
The Business Case for Diversity: Dynamic Strategies for Promoting Diversity and Inclusion
photo
Dr. Nathan Dolloff
CHIEF SCIENTIFIC OFFICER, LEUKOGENE THERAPEUTICS, INC.
Leukogene Therapeutics, Inc
Charleston, South Carolina, United States
photo
Mikael Dolsten
CHIEF SCIENTIFIC OFFICER AND PRESIDENT, WORLDWIDE RESEARCH, DEVELOPMENT AND MEDICAL, PFIZER, INC.
New Models for Translational Research Collaboration
photo
Dr. David Donabedian, PhD
CO-FOUNDER, CEO AND DIRECTOR, AXIAL BIOTHERAPEUTICS
What’s Next: The Landscape of Innovation in 2019 and Beyond
Cambridge, Massachusetts, United States
photo
Mr. Alain Dong, MBA, PhD
MANAGING PARTNER, CHINA IPWELL LAW FIRM
Patentable Subject Matter Around the World: Life Science Inventions in Canada, Europe, China, Australia and New Zealand
Shanghai, China
photo
Ms. Elizabeth Donley, JD, MBA, MS
CEO, NEUROPOINTDX
Precision Medicine Beyond Oncology
Madison, Wisconsin, United States
photo
Dr. Kat Donnelly
FOUNDER AND CO-CEO, AZENTIVE
AZENTIVE
Palm Springs, California, United States
photo
Dana Dornsife
CHAIRMAN OF THE BOARD, LAZAREX CANCER FOUNDATION
How To Boost Racial, Ethnic and Gender Diversity in Clinical Research
photo
Marion Dorsch, PhD
CHIEF SCIENTIFIC OFFICER, BLUEPRINT MEDICINES
The Art & Science of R&D Innovation and Productivity
photo
Dr. William Dowling
CHIEF, BIODEFENSE RESEARCH RESOURCES SECTION, NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID)
Technology Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Innovation
photo
Dr. John Doyle
VICE PRESIDENT, GLOBAL HEALTHCARE INNOVATION LEAD, PFIZER INC.
How to Ensure Access Doesn’t Get in the Way of Good Science
The International Pricing Index: What will be the Impact on Patients, Outcomes, and Innovation?
photo
Dr. Tao Tom Du, MD, PhD
CHIEF BUSINESS OFFICER, GUANGZHOU SINOGEN PHARMACEUTICAL CO.，LTD.
Guangzhou Sinogen Pharmaceutical Co., Ltd.
Guangzhou, China
photo
Dr. Sonya Dumanis
SENIOR DIRECTOR OF INNOVATION, EPILEPSY FOUNDATION
Epilepsy Foundation
Landover, Maryland, United States
photo
Doug Edgeton
PRESIDENT AND CEO, NORTH CAROLINA BIOTECHNOLOGY CENTER
Technology-Based Economic Development: Evolving Models, Strategies and Finance Approaches
Research Triangle Park, North Carolina, United States
photo
John Edwards
CEO, DRUSOLV THERAPEUTICS
Drusolv Therapeutics
Philadelphia, Pennsylvania, United States
photo
Mrs. Carina Edwards, MBA
CEO, QUIL
Digital Integration in Healthcare: Real-World Scenarios from Leading Healthcare Institutions & Fireside Chat with Carina Edwards, CEO, Quil
photo
Mr. Andy Eibling
VP, ALLIANCE MANAGEMENT AND BUSINESS DEVELOPMENT, ENABLE INJECTIONS, INC.
Enable Injections, Inc.
Cincinnati, Ohio, United States
photo
Dr. Harietta Eleftherochorinou, MENG, MSc, PhD
PRACTICE LEADER, GLOBAL | MACHINE LEARNING & ARTIFICIAL INTELLIGENCE SOLUTIONS, REAL WORLD & ANALYTICS, IQVIA
Machine Learning and Artificial Intelligence: Realizing Precision Medicine One Patient at a Time
London, United Kingdom
photo
Dr. Ake Elhammer
CEO, AUREOGEN BIOSCIENCES, INC.
AureoGen Biosciences, Inc.
Kalamazoo, Michigan, United States
photo
Michael Elliott, MBBS, PhD
VP, IMMUNOLOGY SCIENTIFIC INNOVATION, JOHNSON & JOHNSON INNOVATION
The Business of Microbiomes: Translating Research into Evidence-Based Clinical Products
photo
Dr. Niels Emmerich
VICE PRESIDENT, GLOBAL HEAD SEARCH AND EVALUATION, ABBVIE
AbbVie
North Chicago, Illinois, United States
photo
Leonor Enes
SCIENTIFIC OFFICER, EUROPEAN MEDICINES AGENCY
Brexit and the Impact on the Biotechnology Industry
Patient-Focused Drug Development: From Concept to Reality
photo
Sebastian Engels
ATTORNEY AT LAW (GERMANY), BOEHMERT & BOEHMERT
Transparency of clinical trial data – A hidden treasure, a ticking bomb or a regulatory reality
photo
Steve England
CHIEF SCIENCE OFFICER, 3SCAN
3Scan
San Francisco, California, United States
photo
Dr. Claudia Englbrecht
DIRECTOR, BIO DEUTSCHLAND, E.V.
Referencing European Prices for Medicare Part B Drugs
Berlin, Germany
photo
Jonathan A. Epstein, MD
EXECUTIVE VICE DEAN AND CHIEF SCIENTIFIC OFFICER WILLIAM WIKOFF SMITH PROFESSOR OF CARDIOVASCULAR RESEARCH DEPARTMENT OF MEDICINE, PERELMAN SCHOOL OF MEDICINE UNIVERSITY OF PENNSYLVANIA
New Models for Translational Research Collaboration
photo
Cartier Esham
EXECUTIVE VICE PRESIDENT, EMERGING COMPANIES, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Fireside Chat with Dr. Norman Sharpless, Acting Commissioner, US Food and Drug Administration
The State of Innovation in Highly Prevalent Chronic Diseases
photo
Dr. Gloria Esposito
CHIEF TECHNOLOGIST, TRIANNI.COM
Trianni, Inc
Vienna, Austria
photo
Sandy Estrada, PharmD
VICE PRESIDENT, MEDICAL AFFAIRS, T2 BIOSYSTEMS, INC.
Diagnostics for Infectious Diseases
photo
Mr. Eric Falcand
VP, GLOBAL HEAD OF BUSINESS DEVELOPMENT & LICENSING, SERVIER
Servier
Suresnes, France
photo
Marie-Helene Fandel
, AMGEN
CANCELLED Real World Evidence: What Role can it Play in Assessing the Value of Innovative Medicines in Europe?
photo
Jane Fang, MD, MS
DIRECTOR, R&D INFORMATION HEAD FOR CLINICAL BIOLOGICS , ASTRAZENECA
Disruptive Innovation in Clinical Trials: Tools to Accelerate Recruitment
photo
Dr. Gary Fanger
PRESIDENT & CEO, RISE THERAPEUTICS, LLC
Rise Therapeutics, LLC
Rockville, Maryland, United States
photo
Diane Farrell
DEPUTY ASSISTANT SECRETARY FOR ASIA, U.S. DEPARTMENT OF COMMERCE, INTERNATIONAL TRADE ADMINISTRATION
The Drug Pricing Reform Initiative in Japan: Implications on Patient Access, Investment, and Innovation
photo
James Fatheree
EXECUTIVE DIRECTOR, GR GROUP ASIA
The Drug Pricing Reform Initiative in Japan: Implications on Patient Access, Investment, and Innovation
photo
Megan Feeney
SENIOR MANAGER, COMMUNITY ENGAGEMENT, PARKINSON'S FOUNDATION
More Than Just a Buzzword: Tools and Methods for Building Patient Engagement into Your Organization
New York, New York, United States
photo
Kristin Feerst
, INTEGRATED SOLUTIONS AT PALL BIOSCIENCES
Gene Therapies : How to make disruptive innovation affordable for patients ?
photo
Evan Feinberg
FOUNDER AND CEO, GENESIS THERAPEUTICS
Power of AI/ML in Biopharma Drug Discovery and Development
photo
Wenmeng Feng
RESEARCH FELLOW, DEVELOPMENT RESEARCH CENTER OF THE STATE COUNCIL OF THE PEOPLE'S REPUBLIC OF CHINA (DRC)
China Summit Segment III: SPOTLIGHT: Aging China and the Implications for Healthcare
photo
Ms. Stephanie Fertig
DIRECTOR, NINDS SMALL BUSINESS PROGRAMS, NATIONAL INSTITUTES OF HEALTH (NIH)
Opportunities for Industry within Government Neuroscience Initiatives to Tackle Difficult Health Challenges
Bethesda, Maryland, United States
photo
Dr. Daniel Figeys
PRESIDENT, MEDBIOME
MedBiome
Ottawa, Ontario, Canada
photo
Dr. Mitchell Finer
EXECUTIVE PARTNER, MPM CAPITAL
Opportunities and Challenges of Cell and Gene Therapy Development
Cambridge, Massachusetts, United States
photo
Simone Fishburn
VICE PRESIDENT, BIOCENTURY AND BIOCENTURY INNOVATIONS
Digital Health in Practice: A Conversation with Ameet Nathwani, Chief Digital Officer, Chief Medical Officer and Member of the Executive Committee, Sanofi
photo
Wainwright Fishburn
PARTNER, COOLEY
DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy
Investors Corner: Perspectives and Predictions for 2019 and Beyond
photo
Dr. Robert Fisher
SENIOR ADVISOR FOR CBRN AND PANDEMIC INFLUENZA, U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Technology Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Innovation
photo
Dr. Mike Fisher, PhD
COMMERCIAL DIRECTOR, ONCIMMUNE
Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
London, United Kingdom
photo
Dr. Nicole Fitzpatrick
PRODUCT MANAGER, VITAL INNOVATION
Innovative Models for Real World Evidence: Creating Value-Based Precision Health
Pittsburgh, Pennsylvania, United States
photo
Mr. Kurt Foreman
PRESIDENT & CEO, DELAWARE PROSPERITY PARTNERSHIP
Delaware - Global Innovation Hub
Wilmington, Delaware, United States
photo
Mani Foroohar
MANAGING DIRECTOR, GENETIC MEDICINES, SVB LEERINK
Complex CNS diseases: The Next Frontier in AAV Gene Therapy
photo
John Fowler
VICE CHAIRMAN OF HEALTHCARE INVESTMENT BANKING, WELLS FARGO SECURITIES, LLC
The New World of Life Sciences M&A Valuation: Strategies to Adapt and Thrive
photo
Jonathan Fox
PRESIDENT AND CMO, EIDOS
Rare Finds: Innovative Clinical Trial Design for Rare and Orphan Diseases
photo
Phyllis Foxworth
ADVOCACY VICE PRESIDENT, DEPRESSION AND BIPOLAR SUPPORT ALLIANCE
Addressing Unmet Need in Depression
photo
Dr. Ellen Frank
CHIEF SCIENTIFIC OFFICER, HEALTHRHYTHMS, INC.
HealthRhythms, Inc.
New York, New York, United States
photo
Mark Frasier, Ph.D.
SENIOR VICE PRESIDENT, RESEARCH PROGRAMS, THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
A New Era: AI-Based Precision Medicine & Neurological Disorders
photo
Prof. Ian Frazer
IMMUNOLOGIST, CEO, AND DIRECTOR OF RESEARCH, TRANSLATIONAL RESEARCH INSTITUTE
Spurring Biotech Innovation in Global Markets
Australia's Medical Research Landscape: Professor Ian Frazer AC
Australia's Medical Research Landscape: Professor Ian Frazer AC
Kenneth Frazier
Kenneth Frazier
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER, MERCK & CO, INC.
Fireside Chat with Kenneth C. Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co., Inc.
photo
Leonard Freedman
CSO, FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH
Novel Approaches to Improve Reproducibility in Academia-Industry Collaborations
Washington, United States
photo
Jonathan Freeman
SENIOR ADVISOR, BLACKSTONE LIFE SCIENCES
Addressing Unmet Need in Cardiovascular Disease
photo
Danielle Friend, PhD
DIRECTOR, SCIENCE AND REGULATORY AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Opioids: Changing the paradigm of treating pain and addiction - one year later
NIH as a Catalyst: Developing the Next Generation of Pain and Addictions Treatments
The Regulatory Environment for Pain and Addiction Therapies
photo
Adi Frish
SENIOR VP BUSINESS DEVELOPMENT AND LICENSING, REDHILL BIOPHARMA
RedHill Biopharma (NASDAQ:RDHL)
Tel Aviv, Israel
photo
Dew Fromkin
PRESIDENT, CEO AND CHAIRMAN, TARVEDA THERAPEUTICS
Tarveda Therapeutics, Inc
Watertown, Massachusetts, United States
photo
Sohei Fukuyama, MBA
HEAD OF BUSINESS DEVELOPMENT, US, JAPAN AND SOUTH KOREA, MEDINCELL
MedinCell
Montpellier, France
photo
Niki Gallo, RAC
SENIOR CONSULTANT, HALLORAN CONSULTING GROUP
Opportunities and Challenges of Cell and Gene Therapy Development
Boston, Massachusetts, United States
photo
Mr. Jeff Galvin
CEO, AMERICAN GENE TECHNOLOGIES
American Gene Technologies
Rockville, Maryland, United States
photo
Dr. Veronica Gambillara Fonck
CEO, LIMMATECH BIOLOGICS
LimmaTech Biologics
Schlieren, Switzerland
photo
Gail Gannon
MANAGING DIRECTOR, WAVEEDGE CAPITAL
Family Offices, Foundations, Impact Investors, and Venture Accelerators: How They Play the Game
photo
Zhenhai Gao, PhD
FOUNDER AND PRESIDENT, NIKANG THERAPEUTICS
NiKang Therapeutics
photo
Chris Garabedian
CHAIRMAN AND CEO, XONTOGENY, LLC
What’s Next: The Landscape of Innovation in 2019 and Beyond
photo
Arpa Garay
PRESIDENT OF GLOBAL PHARMA, MERCK
Changing the Game: Breaking Down Barriers and Building Up the Next Generation
photo
Ms. Mary Gardner
CEO, DELNOVA, INC.
DelNova, Inc.
San Diego, California, United States
photo
Dr. Denise Gavin
ACTING GENE THERAPY BRANCH CHIEF, DIVISION OF CELL AND GENE THERAPY, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), FDA
Genome Editing and Regulatory Harmonization: Progress and Challenges
photo
Georgia Gavriilidou
COUNSEL, FOOD, DRUG AND MEDICAL DEVICE REGULATORY LIFE SCIENCES, SIDLEY AUSTIN LLP
Genome Editing and Regulatory Harmonization: Progress and Challenges
photo
Dr. Dan Gebremedhin
PARTNER, FLARE CAPITAL
Investors Corner: Perspectives and Predictions for 2019 and Beyond
photo
Dr. Bruce Gellin
PRESIDENT, SABINE INSTITUTE
The Future of Influenza Vaccines
Washington, District Of Columbia, United States
photo
Andrei Georgescu
PH.D. CANDIDATE, DEPARTMENT OF BIOENGINEERING, UNIVERSITY OF PENNSYLVANIA
Tissue Engineering Onboard the International Space Station
photo
Julie Gerberding
EXECUTIVE VICE PRESIDENT & CHIEF PATIENT OFFICER, MERCK & CO, INC.
Understanding the Voices of Patients: Unique Perspectives on Healthcare
photo
Matt Gevaert
CEO, KIYATEC, INC
Humans-in-a-Dish: Hope or Hype?
Greenville, South Carolina, United States
photo
Albert Gianchetti
PRESIDENT & CEO, XYLOCOR THERAPEUTICS
XyloCor Therapeutics
Malvern, Pennsylvania, United States
photo
Derek Giersch
HEAD OF ACCOUNT MANAGEMENT, BRIGHTINSIGHT
DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy
photo
Dr. Antoni Gilabert Perramon
DIRECTOR OF PHARMACY AND MEDICINES, CATALAN HEALTH AND SOCIAL CARE CONSORTIUM
New Approaches to Reimbursement for Gene Therapy: What Can We Learn From Models Currently in Practice?
Barcelona, Spain
photo
Doug Giordano, MBA
SENIOR VP, WORLDWIDE BUSINESS DEVELOPMENT, PFIZER INC
The New World of Life Sciences M&A Valuation: Strategies to Adapt and Thrive
New York, New York, United States
photo
Suzanne Giordano
HEAD OF FIELD MEDICAL, SUNOVION PHARMACEUTICALS
More Than Just a Buzzword: Tools and Methods for Building Patient Engagement into Your Organization
photo
John Glasspool
CEO AND MEMBER, BOARD OF DIRECTORS, ANTHOS THERAPEUTICS
Addressing Unmet Need in Cardiovascular Disease
photo
Dr. Marcie Glicksman
CHIEF SCIENTIFIC OFFICER, ORIG3N, INC
Orig3n
Boston, Massachusetts, United States
photo
Paul Golian
VICE PRESIDENT & ASSISTANT GENERAL COUNSEL, BRISTOL-MYERS SQUIBB
The BPCIA is Turning Ten: What's Next for Biosimilars?
photo
Phil Golz
VICE PRESIDENT FOR HEALTHCARE STRATEGY AND SALES, SPIRE
Powered by BARDA – Innovative Government Models
photo
Reyna Gomez-Flores
PH. D., LAMBTON COLLEGE
Is Hand-Me-Down Separation Technology Holding Back the Bioeconomy?
Colwich , Kansas, United States
photo
Asthika Goonewardene
SENIOR BIOTECHNOLOGY ANALYST, BLOOMBERG INTELLIGENCE
Immuno-Oncology: Taking Immunotherapies to the Next Level
photo
Erynn Gordon
VP CLINICAL OPERATIONS, GENOME MEDICAL
Genome Medical
photo
Wyatt Gotbetter
PARTNER, HEALTH ADVANCES
Business Development Fundamentals Day 2
photo
Phil Gotwals
HEAD, SEARCH & EVALUATION, NIBR BD&L, NOVARTIS
Novartis
Cambridge, Massachusetts, United States
photo
Frank Goudsmit, CPCU
SVP, LIFE SCIENCES, CHUBB
De-Risking Life Sciences Mergers and Acquisitions
Saint Louis, Missouri, United States
photo
Lisa Gray
MANAGING PARTNER, PIPV CAPITAL
Persuasive Pitching: Do You Have the Talent to Engage Investors?
photo
Mrs. Judith Greciet
CEO, ONXEO
ONXEO
Paris, France
photo
Dr. Anthony Green
VICE PRESIDENT OF TECHNOLOGY COMMERCIALIZATION, BEN FRANKLIN TECHNOLOGY PARTNERS
Technology-Based Economic Development: Evolving Models, Strategies and Finance Approaches
Philadelphia, Pennsylvania, United States
photo
Dr. Larry Green
CEO, ALIVAMAB DISCOVERY SERVICES AND ABLEXIS
AlivaMab Discovery Services & Ablexis
San Diego, California, United States
photo
Yvonne Greenstreet
COO, ALNYLAM
Diversity : A Business Imperative for the Life Sciences Industry
photo
Hon. James C Greenwood
PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
BIO 2019 Governor’s Fireside Chat
Washington, District Of Columbia  , United States
photo
Guy Greiveldinger, MBA, PhD
HEAD OF PRECISION MEDICINE BD&L, NOVARTIS
The Changing Landscape in Pharma/Diagnostic Partnerships
Basel, Switzerland
photo
Michele Grimm
PROGRAM MANAGER, BIOMEDICAL ENGINEERING PROGRAM, NATIONAL SCIENCE FOUNDATION
Tissue Engineering Onboard the International Space Station
photo
Bernard Grimm
HEALTHCARE DIRECTOR, EUROPABIO
Brexit and the Impact on the Biotechnology Industry
photo
Ancizar Guerrero Gil
FOREIGN INVESTMENT EXECUTIVE DIRECTOR IN THE UNITED STATES, PROCOLOMBIA
There is $200B in Global Investment in the Biopharmaceutical Sector Each Year. Who’s Getting It and Why?
Colombia
photo
Dr. Sheila Gujrathi
CEO, GOSSAMER BIO
Gossamer Bio
San Diego, California, United States
photo
Stefano Gulla
CEO, ABCURO
Abcuro, Inc.
Boston, Massachusetts, United States
photo
Dr. Moira Gunn
JOURNALIST & PROFESSOR, TECH NATION MEDIA
Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
San Francisco, California, United States
photo
Tong Guo
HEAD OF BIOSTATISTICS, SOUTH AFRICA AND ASIA, IQVIA BIOTECH
Machine Learning and Artificial Intelligence: Realizing Precision Medicine One Patient at a Time
photo
Swati Gupta
VICE PRESIDENT, RESEARCH INTEGRATION & INNOVATION, INTERNATIONAL AIDS VACCINE INITIATIVE
Advances in HIV Treatment and Prevention
Platform technologies: Powering Commercial and Outbreak Development
photo
Dr. Mark Gurney
CHAIRMAN & CEO, TETRA DISCOVERY PARTNERS, INC.
Opportunities for Industry within Government Neuroscience Initiatives to Tackle Difficult Health Challenges
Grand Rapids, Michigan, United States
photo
Gary Gustavsen
PARTNER AND MANAGING DIRECTOR, PRECISION MEDICINE, HEALTH ADVANCES
From Diagnostics to Treatment and Back Again in the Digital Era
photo
Meghan Gutierrez
CHIEF EXECUTIVE OFFICER, LYMPHOMA RESEARCH FOUNDATION
Valuing a Transformative Cancer Therapy: Perspectives on CAR T from Across the Healthcare Industry
photo
Ms. Kimberly Ha
CEO, KKH ADVISORS
Beyond Dementia: The REALLY Big Opportunities in Neuroscience
New York, New York, United States
photo
Dr. Yacoub Habib
CEO, OPHIDION, INC.
Ophidion, Inc.
Bethlehem, Pa, Pennsylvania, United States
photo
Dr. Kyungsoo Hahm
DIRECTOR, BIOLEADERS
Bioleaders Corporation
Yongin-si, Gyeonggi-do, Korea - South Korea
photo
William N. Hait, MD, PhD
GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON INNOVATION
Biotech’s Contribution to Innovation: Current and Future Drivers of Success
photo
Marian Hajduch
SCIENTIFIC DIRECTOR, IMTM
Novel Approaches to Improve Reproducibility in Academia-Industry Collaborations
Olomouc, Czech Republic
photo
Dr. Julia Haller
OPHTHALMOLOGIST-IN-CHIEF, WILLS EYE HOSPITAL
The Science of Shattering the Lab’s Glass Ceiling
photo
Dr. Christiane Hamacher
CEO, BIOCON BIOLOGICS INDIA LIMITED
India's Contribution in Global Biotech R&D
photo
Margaret Hamburg, MD
FOREIGN SECRETARY, NATIONAL ACADEMY OF MEDICINE, CHAIRMAN OF THE BOARD, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE
Fireside Chat with Margaret (Peggy) Hamburg, MD, Foreign Secretary, National Academy of Medicine; Chairman of the Board, American Association for the Advancement of Science
Regulatory Strategies to Facilitate Access to Global Outbreak Vaccines
photo
Dr. Marianne Hamilton Lopez
RESEARCH DIRECTOR, DUKE-ROBERT J. MARGOLIS, MD, CENTER FOR HEALTH POLICY
The Path Forward for Value-Based Payment for Transformative Therapies
photo
Richard Hanbury
CEO, SANA.IO
The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies
LAFAYETTE, Colorado, United States
photo
Andrei Hancharou
DIRECTOR, INSTITUTE OF BIOPHYSICS AND CELL ENGINEERING BELARUS
Eurasian Economic Union/Eurasia - Global Innovation Hub
photo
Kevin Haninger, PhD
VICE PRESIDENT, INTERNATIONAL ADVOCACY, PHRMA
The Drug Pricing Reform Initiative in Japan: Implications on Patient Access, Investment, and Innovation
photo
Emmanuel Hanon
SENIOR VICE PRESIDENT, HEAD OF VACCINES RESEARCH AND DEVELOPMENT, GLAXOSMITHKLINE
Platform technologies: Powering Commercial and Outbreak Development
photo
Dr. Mitsunobu Hara
DIRECTOR, BUSINESS DEVELOPMENT AND INTELLECTUAL PROPERTY, ACCURNA INC.
AccuRna Inc.
Tokyo, Japan
photo
Prof. Dror Harats
CEO, VASCULAR BIOGENICS LTD
Vascular Biogenics Ltd
Modiin, Israel
photo
Sarah Hardison, PhD
THERAPEUTIC AREA DIRECTOR, IMMUNOLOGY & IMMUNO-ONCOLOGY, CLARIVATE ANALYTICS
Immuno-oncology Investment: Building Biology
photo
Dr. Mark Hasleton, MBA, PhD
VP, BUSINESS DEVELOPMENT , ORAMED PHARMACEUTICALS
Oramed Pharmaceuticals
Jerusalem, Israel
photo
Richard Hatchett
CEO, COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI)
Regulatory Strategies to Facilitate Access to Global Outbreak Vaccines
photo
Elaine Haynes
PRESIDENT & CEO, KALOCYTE, INC.
KaloCyte, Inc.
St. Louis, Missouri, United States
photo
Ms. Sarah Haywood, BSc, MA
DIRECTOR, ADVANCED THERAPIES NETWORK POWERED BY MEDCITY
Advanced Therapies Network
London , United Kingdom
photo
Daria Hazuda, PhD
VICE-PRESIDENT AND THERAPEUTIC AREA HEAD, INFECTIOUS DISEASE AND VACCINES, CSO, MERCK CAMBRIDGE EXPLORATORY SCIENCE CENTER, MERCK RESEARCH LABS, MERCK
Advances in HIV Treatment and Prevention
photo
Monica He
DIRECTOR, INTERNATIONAL AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION
China Summit Segment III: SPOTLIGHT: Aging China and the Implications for Healthcare
photo
Jim Healy, MD, PhD
GENERAL PARTNER, SOFINNOVA VENTURES
Swinging for the Fences: The Dichotomy in Rare Disease Investment and Development
Menlo Park, California, United States
photo
Aileen Healy
EXECUTIVE DIRECTOR, GLOBAL HEAD, ES&I FOR RARE DISEASES, WORLDWIDE R&D, PFIZER
Rare Finds: Innovative Clinical Trial Design for Rare and Orphan Diseases
Boston, Massachusetts, United States
photo
Curtis Hecht
CHIEF BUSINESS OFFICER, CALITHERA BIOSCIENCES
Get Relevant or Go Home: Shedding Light on Oncology R&D Sums
photo
Mary Hecht-Kissell
BUSINESS DEVELOPMENT DIRECTOR, NORTH CAROLINA BIOTECHNOLOGY CENTER
North Carolina, USA - Global Innovation Hub
Research Triangle Park, North Carolina, United States
photo
Mo Heidaran
VICE PRESIDENT TECHNICAL, REGULATORY AND TECHNICAL CMC CONSULTING CELL, GENE THERAPY AND TISSUE ENGINEERING, PAREXEL INTERNATIONAL
Update on the Evolving Global Gene Therapy Regulatory Policy Landscape
photo
Jennifer Heller
ASSOCIATE PARTNER, MCKINSEY & COMPANY
The State of the Vaccine Industry: Stimulating Sustainable Growth
photo
Mr. Per Hellsund
CEO, CYBREXA THERAPEUTICS
Cybrexa Therapeutics
New Haven, Connecticut, United States
photo
Nicole Hemmenway
INTERIM CEO, U.S. PAIN FOUNDATION
Opioids: Changing the paradigm of treating pain and addiction - one year later
photo
Peter Hennessey
PARTNER, BALLARD SPAHR LLP
Blazing a Trail: Lessons on Bringing a New Technology to Market
Philadelphia, Pennsylvania, United States
photo
Col. Matthew Hepburn
PHYSICIAN, U.S. ARMY
2019 National Health Security Forum: Partnering with the U.S. Government for Rapid Response to Biological Threats
Arlington, Virginia, United States
photo
Curt Herberts
CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER, SENTI BIOSCIENCES, INC.
What’s Next: The Landscape of Innovation in 2019 and Beyond
photo
Dr. Christina Herder
EVP, STRATEGIC BUSINESS DEVELOPMENT, MEDIVIR AB
Medivir AB
Huddinge, Stockholm, Sweden
photo
David Hering
REGIONAL PRESIDENT, NORTH AMERICA, PFIZER VACCINES
The State of the Vaccine Industry: Stimulating Sustainable Growth
photo
Patrick Heron
MANAGING GENERAL PARTNER, FRAZIER HEALTHCARE PARTNERS
Sustainable Financing – Are We Building Half a Bridge?
photo
Lauren Hetrick
SENIOR DIRECTOR, REGULATORY POLICY AND INTELLIGENCE, ABBVIE
Patient-Focused Drug Development: From Concept to Reality
Rockville, Maryland, United States
photo
Dr. James "J" Hickman
CHIEF SCIENTIST, HESPEROS, INC.
Hesperos, Inc.
Orlando, Florida, United States
Katherine High
Katherine High , MD
PRESIDENT AND HEAD OF RESEARCH AND DEVELOPMENT, SPARK THERAPEUTICS
The Science of Shattering the Lab’s Glass Ceiling
Realizing the Promise of Gene Therapies for Patients Around the World
Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future
London, Colorado, United States
photo
Sarah Hill
CEO, HEALIUM BY STORYUP
The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies
photo
Dr. Michael Hill
PROFESSOR OF NEUROLOGY, UNIVERSITY OF CALGARY
Beyond Dementia: The REALLY Big Opportunities in Neuroscience
Calgary, Alberta, Canada
photo
Paulina Hill
PRINCIPAL, OMEGA FUNDS
Role of Scientific Founders Over the Lifetime of a Company
photo
Elizabeth Hillebrenner
ASSOCIATE DIRECTOR FOR PROGRAMS AND PERFORMANCE, OFFICE OF IN VITRO DIAGNOSTICS & RADIOLOGICAL HEALTH, U.S. FOOD AND DRUG ADMINISTRATION
Precision Medicine and the FDA: Prospects for Regulation of Laboratory Developed Tests
photo
Mr. Seiji Hirasaki
CEO, ORICIRO GENOMICS
OriCiro Genomics
Tokyo, Japan
photo
Eamonn Hobbs
CHAIRMAN, PRESIDENT, CEO, IMMUNSYS™ INC.
ImmunSYS™ Inc.
Fort Lauderdale, Florida, United States
photo
Dr. Keith Hoffman
VICE PRESIDENT OF BUSINESS DEVELOPMENT & TECH TRANSFER, THE LUNDQUIST INSTITUTE (FORMERLY LA BIOMED)
The Lundquist Institiute (formerly LA BioMed)
Torrance, California, United States
photo
Ryan Hohman
VICE PRESIDENT OF PUBLIC AFFAIRS , FRIENDS OF CANCER RESEARCH
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned from a Novel Pilot Program
Washington, District Of Columbia  , United States
photo
Mr. Ben Hohn
PRINCIPAL - BD, PIPELINE AND LAUNCH STRATEGY, ZS ASSOCIATES, INC.
Oncology “First Launch” and Partnering
New York, New York, United States
photo
Dr. Ben Holmes
CEO, NANOCHON
Nanochon
Washington DC, United States
photo
Peter Johannes Holst
CEO AND CSO, INPROTHER
InProTher
photo
Sönke Holtorf
DIRECTOR HBC | DIRECTORATE 1.1.1.1, EUROPEAN PATENT OFFICE
Pitfalls for US Applicants When Filing Patent Applications at the EPO
photo
Dr. Barry Holtz
PRESIDENT, IBIO CDMO, IBIO INC.
iBio Inc.
Bryan, Texas, United States
photo
Dr. David Hone
CHIEF SCIENTIST, VACCINE AND THERAPEUTIC DIVISION, JOINT SCIENCE AND TECHNOLOGY OFFICE (JSTO), DEFENSE THREAT REDUCTION AGENCY (DTRA)
Technology Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Innovation
photo
Dr. Zhi Hong, PhD
CO-FOUNDER, PRESIDENT, AND CHIEF EXECUTIVE OFFICER, BRII BIOSCIENCES
Brii Biosciences
Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future
Durham, North Carolina, United States
photo
Dr. J. Kenneth Hoober, PG, PhD
CHIEF SCIENTIFIC OFFICER, SUSAVION BIOSCIENCES, INC.
Susavion Biosciences, Inc.
Tempe, Arizona, United States
photo
Mr. Eric Horler
CEO, AIQ SOLUTIONS, INC.
AIQ Solutions, Inc.
Madison, Wisconsin, United States
photo
Arthur Horwich
STERLING PROFESSOR OF GENETICS AND PROFESSOR OF PEDIATRICS; INVESTIGATOR HHMI, YALE UNIVERSITY
Falling in Love with Science: Championing Science for Everyone, Everywhere
photo
Michael Hostetler
PARTNER, WILSON SONSINI GOODRICH AND ROSATI, P.C.
How Early is Too Early? Valuing and De-Risking Preclinical Opportunities
photo
Yan Hou
VICE CHAIRPERSON, CHINA ASSOCIATION OF MEDICAL EQUIPMENT
China Summit Segment III: SPOTLIGHT: Aging China and the Implications for Healthcare
photo
David Hough, MD
ESKETAMINE COMPOUND DEVELOPMENT TEAM LEADER , JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Addressing Unmet Need in Depression
photo
Dr. John Howard
PRESIDENT, ABI
Applied Biotechnology Institute, Inc.
San Luis Obispo, California, United States
photo
Mr. Kevin Hrusovsky
CHAIRMAN AND CEO, QUANTERIX
Quanterix
Lexington, Massachusetts, United States
photo
Dr. Dar-Jen Hsieh
CEO, ACRO BIOMEDICAL CO., LTD.
ACRO Biomedical Co., Ltd.
Kaohsiung, Taiwan
photo
Dr. John Hsu
CEO FOUNDER , IPILL DISPENSER
IPill dispenser
Rowland Heights , California, United States
photo
Jing-Shan Hu
PARTNER, QIMING VENTURE PARTNERS
The Evolving Landscape of Venture Capital
San Francisco, California, United States
photo
Mei Mei Hu
CHIEF EXECUTIVE OFFICER , UNITED NEUROSCIENCE LTD.
Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots
Dublin, Ireland
photo
Dr. Jim Huang
CEO, ASCENDIA PHARMACEUTICALS
Ascendia Pharmaceuticals
N. Brunswick, New Jersey, United States
photo
Jed Hubbs
CEO, NEUROCYCLE THERAPEUTICS
Neurocycle Therapeutics
Cambridge, Massachusetts, United States
photo
Brady Huggett
BUSINESS EDITOR, NATURE BIOTECHNOLOGY
The Science of Shattering the Lab’s Glass Ceiling
photo
Dr. Zoe Hughes, PhD
SENIOR DIRECTOR, PRAXIS PRECISION MEDICINES
NIH as a Catalyst: Developing the Next Generation of Pain and Addictions Treatments
Cambridge, Massachusetts, United States
photo
Dr. Thomas Hughes
CEO, NAVITOR PHARMACEUTICALS
Anti-Aging Therapies: Taking Action to Increase the Human Healthspan
Cambridge, Massachusetts, United States
photo
Dr. Gjalt Huisman
SR VP STRATEGIC DEVELOPMENT, CODEXIS
Codexis
Redwood City, California, United States
photo
Hans Hull, JD
CHIEF BUSINESS OFFICER, PLIANT THERAPEUTICS
Role of Scientific Founders Over the Lifetime of a Company
South San Francisco, California, United States
photo
Dr. Richard Hurtig
CHIEF SCIENTIFIC OFFICER, VOXELLO
Voxello
Coralville, Iowa, United States
photo
Albert Hwang, MD
MANAGING DIRECTOR, HEALTHCARE INVESTMENT BANKING, MORGAN STANLEY
Realizing the Promise of Gene Therapies for Patients Around the World
photo
Dr. Crystal Icenhour
CEO AND CO- FOUNDER, APERIOMICS, INC.
Aperiomics, Inc.
Ashburn, VA, Virginia, United States
photo
Dr. Nicusor Iftimia, PhD
AREA MANAGER, PHYSICAL SCIENCES INC
Physical Sciences, Inc.
Andover, Massachusetts, United States
photo
Mr. Keith Ignotz, MBA
PRESIDENT & CEO, OCUMEDICS, INC.
OcuMedic, Inc.
Charlottesville, Virginia, United States
photo
Dr. Sara Imhof, PhD
SENIOR DIRECTOR, NORTH CAROLINA BIOTECHNOLOGY CENTER
Innovative Models for Real World Evidence: Creating Value-Based Precision Health
Durham, North Carolina, United States
photo
Mr. Howard Isenstein, MA
FOUNDER, DIGIDENCE
Digidence
Bethesda, Maryland, United States
photo
Ms. Daniela Iwanski
VP, EXECUTIVE RECRUITER CLINICAL AND COMMERCIAL RECRUITMENT, GOVIG & ASSOCIATES
Govig & Associates
Scottsdale, Arizona, United States
photo
Dennis Jackman
SENIOR VICE PRESIDENT, PUBLIC AFFAIRS, CSL BEHRING
Fireside Chat with Peter Saltonstall, President and Chief Executive Officer, National Organization for Rare Disorders (NORD)
photo
Dr. Alan Jacobs
PRESIDENT AND CHIEF MEDICAL OFFICER, HEMOSTEMIX INC.
Hemostemix Inc. (TSX and OTCQB:TSX V:HEM; OTCQB:HMTXF)
Palo Alto, California, United States
photo
Pravin Jadhav
SENIOR DIRECTOR, INNOVATION AND BUSINESS TRANSFORMATION, CORPORATE PROJECTS, OTSUKA PHARMACEUTICAL COMPANIES (U.S.)
Disruptive Innovation in Clinical Trials: Tools to Accelerate Recruitment
photo
Martin Jakobsen
FOUNDER, STIPE THERAPEUTICS
STipe Therapeutics
photo
Bahija Jallal, PhD
CHIEF EXECUTIVE OFFICER AND DIRECTOR OF THE BOARD, IMMUNOCORE
The Business Case for Diversity: Dynamic Strategies for Promoting Diversity and Inclusion
photo
Dr. Ming-Kuei Jang
CEO, APRINOIA THERAPEUTICS
APRINOIA Therapeutics
Taipei , Taiwan
photo
Dr. Jonathan Javitt
CEO, NEURORX
NeuroRx, Inc.
Wilmington, Delaware, United States
photo
Park Jee Min
DEPUTY DIRECTOR OF THE DIVISION OF HEALTH INDUSTRY PROMOTION, MINISTRY OF HEALTH AND WELFARE (MOHW)
There is $200B in Global Investment in the Biopharmaceutical Sector Each Year. Who’s Getting It and Why?
photo
Julia Jenkins
EXECUTIVE DIRECTOR, EVERYLIFE FOUNDATION
New Hope, Big Challenges: Newborn Screening in the Genetic Era
photo
Dr. Allison Jeynes-Ellis
CEO, AVILLION LLP
Avillion LLP
London, United Kingdom
photo
Amanda Jezek
SENIOR VICE PRESIDENT, PUBLIC POLICY AND GOVERNMENT RELATIONS, INFECTIOUS DISEASES SOCIETY OF AMERICA
It Starts with One Step: Piloting New Payment and Reimbursement Models for Novel Antibiotics in the US
Arlington, Virginia, United States
photo
Diane Johnson
SENIOR DIRECTOR, STRATEGIC REGULATORY, MD&D, JOHNSON & JOHNSON
Current and Future Regulatory Environment for Digital Health
photo
Dr. David Johnson, MBA, PhD
PRESIDENT & CEO, GIGAGEN
Role of Scientific Founders Over the Lifetime of a Company
South San Francisco , California, United States
photo
Mr. Ricardo Johnson, BS, JD
HEALTHWORX AT CAREFIRST BLUECROSS BLUESHIELD, CAREFIRST BLUECROSS BLUESHIELD
The Secret Recipe to Maximizing Deals in Precision Medicine
Baltimore, Maryland, United States
photo
Ms. Sabrina Johnson
CEO, DARé BIOSCIENCE, INC.
Daré Bioscience
San Diego, California, United States
photo
Jullian Jones, PhD, MBA, JD
SENIOR DIRECTOR, ONCOLOGY BUSINESS DEVELOPMENT, ELI LILLY AND COMPANY
Dealmakers' Intentions: 2019 Market Outlook
photo
Hon. Kate Jones, MP
MINISTER FOR INNOVATION AND TOURISM INDUSTRY DEVELOPMENT, QUEENSLAND GOVERNMENT
Spurring Biotech Innovation in Global Markets
photo
Dr. Bruce Edward Jones
PRESIDENT, CEO AND FOUNDER, SCORE PHARMA, INC.
Score Pharma, Inc.
Exton, Pennsylvania, United States
photo
Frederick Jones
PARTNER, BIOADVANCE
Persuasive Pitching: Do You Have the Talent to Engage Investors?
Radnor, Pennsylvania, United States
photo
Dr. Paul Juniewicz
SR. DIRECTOR, ONCOLOGY SEARCH & EVALUATION, TAKEDA
Get Relevant or Go Home: Shedding Light on Oncology R&D Sums
Massachusetts, United States
photo
Vikas Kabra
HEAD, TRANSACTION EXCELLENCE, ROCHE
Dealmakers' Intentions: 2019 Market Outlook
photo
Dr. Robert Kadlec
ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Strategy and Policy Solutions to Rapidly Counter Emerging and Unanticipated Threats: A Role for Collaboration
photo
Dr. Kirill Kaem
SENIOR VICE-PRESIDENT FOR INNOVATIONS, SKOLKOVO FOUNDATION
Russia - Global Innovation Hub
Expanding Early Stage Research Through Global Partnerships
Moscow, Russian Federation
photo
Dr. Larissa Kahr
HEAD OF GENE THERAPY BUSINESS DEVELOPMENT & LICENSING, GENE THERAPY CENTER AUSTRA | TAKEDA
Gene Therapy Center Austria | Takeda
Vienna, Austria
photo
Rasika Kalamegham, PhD
GROUP DIRECTOR, US REGULATORY POLICY, ROCHE-GENENTECH
Rare Diseases: Maximizing Natural History in Clinical Development
photo
John Kamara
FOUNDER, ALPHA HEALTH
Bitcoin Your Data! From Trusted Pharma Silos to Trustless Community-Owned Blockchain-Based Precision Medicine Data Trials
photo
Steven Kanner
CHIEF SCIENTIFIC OFFICER, CARIBOU BIOSCIENCES, INC.
Scientific Advances in Genome Editing: Where are we Today?
photo
Mr. Amit Kapoor
HONORARY CHAIRMAN, INSTITUTE FOR COMPETITIVENESS, INDIA
India's Contribution in Global Biotech R&D
India
photo
Dr. Barry Kappel
PRESIDENT AND CEO, SAPIENCE THERAPEUTICS
Sapience Therapeutics, Inc.
Harrison, New York, United States
photo
William Karesh
EXECUTIVE VICE PRESIDENT FOR HEALTH AND POLICY, ECOHEALTH ALLIANCE
It Starts with One Health: A Guide to Translational Science from Research to Investment
photo
Dr. Cyrus Karkaria
PRESIDENT , LUPIN LIMITED
India's Contribution in Global Biotech R&D
Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies
India
photo
Karolina Karl
INVESTMENT ADVISOR, INVEST LITHUANIA
Lithuania: Global Innovation Hub
photo
David Kaslow, MD
VICE PRESIDENT, ESSENTIAL MEDICINES DIRECTOR, PATH
Sustainable Financing – Are We Building Half a Bridge?
photo
James Kasuboski
SENIOR DIRECTOR, BOEHRINGER INGELHEIM VENTURE FUND
Persuasive Pitching: Do You Have the Talent to Engage Investors?
photo
Dr. Manohar Katakam
CEO, STEROTHERAPEUTICS LLC
Sterotherapeutics LLC
Spring House, Pennsylvania, United States
photo
Bryan Katz
VICE PRESIDENT, SYNEOS ONE, SYNEOS HEALTH
How to Ensure Access Doesn’t Get in the Way of Good Science
Chicago, Illinois, United States
photo
Mr. Daniel Katzman
CEO, UNLEASH IMMUNO ONCOLYTICS, INC.
Unleash Immuno Oncolytics, Inc.
St. Louis, Missouri, United States
photo
Dr. Lawrence Kauvar
SVP AND CSO, TRELLIS BIOSCIENCE LLC
Trellis Bioscience LLC
Redwood City, California, United States
photo
Patricia Keegan, MD
DIRECTOR, DIVISION OF ONCOLOGY PRODUCTS 2, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), FDA
What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
The Value of Progression-Free Survival
photo
Prof. Hans Keirstead
CEO, AIVITA BIOMEDICAL
AIVITA Biomedical
Irvine, California, United States
photo
Curtis Keith
CSO, BLAVATNIK BIOMEDICAL ACCELERATOR, HARVARD UNIVERSITY
Derisking Academic Science: The Unmet Need
Cambridge, Massachusetts, United States
photo
Monique Kelley
DIRECTOR, R&D COMMUNICATIONS, TAKEDA PHARMACEUTICAL COMPANY, LTD.
Changing the Game: Breaking Down Barriers and Building Up the Next Generation
photo
Luke Kempton
PARTNER, PARTNER
Advanced Business Development Day 2
photo
Nick Kenny
CHIEF SCIENTIFIC OFFICER, SYNEOS HEALTH
Finding the Nexus Between Patient and Payer Needs in Rare Disease
photo
Dr. Mickey Kertesz
CEO, KARIUS
Karius
Redwood City, California, United States
photo
Dr. Iya Khalil, PhD
CHIEF COMMERCIAL OFFICER AND CO-FOUNDER, GNS HEALTHCARE
A New Era: AI-Based Precision Medicine & Neurological Disorders
How Could AI Help Cure Cancer in the Next Five Years?
Cambridge, Massachusetts, United States
photo
Rachna Khosla
VICE PRESIDENT, BUSINESS DEVELOPMENT, AMGEN
Deals that Move You: Tips and Tricks for Getting Results
photo
Patrick Kilbride
SENIOR VICE PRESIDENT , THE GLOBAL INNOVATION POLICY CENTER (GIPC)
The International Pricing Index: What will be the Impact on Patients, Outcomes, and Innovation?
photo
Ute Kilger
PARTNER, BOEHMERT & BOEHMERT
Transparency of clinical trial data – A hidden treasure, a ticking bomb or a regulatory reality
photo
Ms. Jeehyun Kim, PhD
SENIOR ANALYST, KOREA BIOTECHNOLOGY INDUSTRY ORGANIZATION
South Korea - Global Innovation Hub
Seongnam-si, Korea - South Korea
photo
Dr. Kyu-Tae Kim
CHIEF SCIENCE OFFICER, ABCLON INC.
AbClon Inc.
Seoul, Korea - South Korea
photo
Mr. Paul Kim
PARTNER, FOLEY HOAG LLP
Precision Medicine and the FDA: Prospects for Regulation of Laboratory Developed Tests
Washington, District Of Columbia  , United States
photo
Dr. J. Joseph Kim, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, INOVIO
Platform technologies: Powering Commercial and Outbreak Development
photo
Mr. Allen King
TEAM LEAD, RARE DISEASE PATIENT HEALTH AND IMPACT, PFIZER
New Approaches to Reimbursement for Gene Therapy: What Can We Learn From Models Currently in Practice?
New York, New York, United States
photo
Mrs. Rachel King
CO-FOUNDER AND CEO, GLYCOMIMETICS
Changing the Game: Breaking Down Barriers and Building Up the Next Generation
Rockville, Maryland, United States
photo
Randal J. Kirk
CHIEF EXECUTIVE OFFICER, INTREXON
It Starts with One Health: A Guide to Translational Science from Research to Investment
photo
Dr. Anton Kiss
PROFESSOR, UNIVERSITY OF MANCHESTER
Is Hand-Me-Down Separation Technology Holding Back the Bioeconomy?
Manchester, United Kingdom
photo
Rune Kjeken
SCIENTIFIC DIRECTOR, ADVANCED THERAPIES, NORWEGIAN MEDICINES AGENCY (NOMA)
Update on the Evolving Global Gene Therapy Regulatory Policy Landscape
photo
Mr. Mike Klein
CEO, GENOMENON
Genomenon
Ann Arbor, Michigan, United States
photo
Michael Kleinrock
DIRECTOR, RESEARCH DEVELOPMENT, IQVIA INSTITUTE FOR HUMAN DATA SCIENCE
Opioids: Changing the paradigm of treating pain and addiction - one year later
photo
Dr. Eric Kmiec
DIRECTOR, GENE EDITING INSTITUTE, CHRISTIANA CARE HEALTH SYSTEM
Can Genome Editing Fulfill Its Promise and Meet Unmet Medical Needs?
Newark , Delaware,
photo
Jeremy Knox
POLICY LEAD, DRUG-RESISTANT INFECTIONS, WELLCOME TRUST
Sustainable Financing – Are We Building Half a Bridge?
photo
Dr. David Koepsell, JD, PhD
CEO, ENCRYPGEN
Bitcoin Your Data! From Trusted Pharma Silos to Trustless Community-Owned Blockchain-Based Precision Medicine Data Trials
Austin, Texas, United States
photo
Neal Koller
CHAIRMAN & CEO, ALPHYN BIOLOGICS, LLC
Alphyn Biologics, LLC
Annapolis, Maryland, United States
photo
Mr. Alexey Konov
PARTNER, RBV CAPITAL
Expanding Early Stage Research Through Global Partnerships
Moscow, Russian Federation
photo
Alex Kopelyan
PROGRAM DIRECTOR & PARTNER, INDIEBIO
Family Offices, Foundations, Impact Investors, and Venture Accelerators: How They Play the Game
photo
Dr. Sophie Kornowski, PhD
SENIOR PARTNER, GURNET POINT CAPITAL
Dealmakers' Intentions: 2019 Market Outlook
Deals that Move You: Tips and Tricks for Getting Results
Cambridge, Massachusetts, United States
photo
Alexander Kort
SENIOR VICE PRESIDENT, CORPORATE DEVELOPMENT, THEMIS BIOSCIENCE GBMH
Regulatory Strategies to Facilitate Access to Global Outbreak Vaccines
photo
Ernest Koschineg
PARTNER, CIPRIANI & WERNER
De-Risking Life Sciences Mergers and Acquisitions
Blue Bell, Pennsylvania, United States
photo
Mr. Shane Kovacs
CHIEF BUSINESS AND FINANCIAL OFFICER, BLUEROCK THERAPEUTICS
BlueRock Therapeutics
New York, New York, United States
photo
Stanley Kowalski
CO FOUNDER AND CEO, FLODESIGN SONICS
FloDesign Sonics
Wilbraham, Massachusetts, United States
photo
Emily Kramer-Golinkoff
CO-FOUNDER, EMILY'S ENTOURAGE
Understanding the Voices of Patients: Unique Perspectives on Healthcare
photo
Phillip Krause, MD
DEPUTY DIRECTOR, OFFICE OF VACCINES RESEARCH AND REVIEW, U.S. FOOD AND DRUG ADMINISTRATION
Regulatory Strategies to Facilitate Access to Global Outbreak Vaccines
photo
Dr. Jenelle Krishnamoorthy
ASSOCIATE VICE PRESIDENT, GLOBAL POLICY, COMMUNICATIONS AND POPULATION HEALTH, MERCK & CO., INC.
It Starts with One Step: Piloting New Payment and Reimbursement Models for Novel Antibiotics in the US
Washington, District Of Columbia  , United States
photo
Kenneth Krisko
, PARTNER, COOLEY LLP
Advanced Business Development Day 3
photo
Sebastian Kronmueller
HEAD OF MOLECULAR SERVICES, SIEMENS HEALTHINEERS
The Changing Landscape in Pharma/Diagnostic Partnerships
photo
Samarth Kulkarni, PhD
CHIEF EXECUTIVE OFFICER, CRISPR THERAPEUTICS
Scientific Advances in Genome Editing: Where are we Today?
photo
Darshan Kulkarni, MS, PharmD
VICE PRESIDENT, REGULATORY STRATEGY & POLICY, SYNCHROGENIX, A CERTARA COMPANY
Transparency of clinical trial data – A hidden treasure, a ticking bomb or a regulatory reality
photo
Seema Kumar
VICE PRESIDENT, INNOVATION, GLOBAL HEALTH AND POLICY COMMUNICATION, JOHNSON & JOHNSON INNOVATION
Falling in Love with Science: Championing Science for Everyone, Everywhere
photo
Dr. Jitendra Kumar
DIRECTOR, BANGALORE BIOINNOVATION CENTRE
Bangalore- Global Innovation Hub
Bangalore, India
photo
Deepak Kumar
RESEARCH ASSISTANT PROFESSOR, AGRICULTURAL AND BIOLOGICAL ENGINEERING, UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Is Hand-Me-Down Separation Technology Holding Back the Bioeconomy?
photo
Katherine Kuzmeskas
CEO, SIMPLYVITALHEALTH.COM
Bitcoin Your Data! From Trusted Pharma Silos to Trustless Community-Owned Blockchain-Based Precision Medicine Data Trials
Sacramento, California, United States
photo
Drew Kuzmission, PhD
SENIOR DIRECTOR, GLOBAL REGULATORY AFFAIRS CMC, VERTEX PHARMACEUTICALS INCORPORATED
Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
Boston, Massachusetts, United States
photo
Joseph La Barge
CHIEF LEGAL OFFICER, SPARK THERAPEUTICS
Blazing a Trail: Lessons on Bringing a New Technology to Market
photo
Dr. Emmanuel Lacroix, MBA, PhD
PARTNER, UCB VENTURES
Persuasive Pitching: Do You Have the Talent to Engage Investors?
The Evolving Landscape of Venture Capital
Brussels, Belgium
photo
Mohamed Ladha
VP AND HEAD OF COMMERCIAL, TOCAGEN
Oncology “First Launch” and Partnering
photo
Janet Lambert
CEO, ARM (ALLIANCE FOR REGENERATIVE MEDICINE)
Opportunities and Challenges of Cell and Gene Therapy Development
photo
Tomas Landh, MSc
INNOVATION SOURCING VICE PRESIDENT, SENIOR PRINCIPAL SCIENTIST R&D EXTERNAL INNOVATION SOURCING, NOVO NORDISK A/S DENMARK
Addressing Unmet Need in Diabetes/Obesity
photo
Mr. Frank Langley
CEO, TAI DIAGNOSTICS, INC.
TAI Diagnostics Inc.
Wauwatosa, Wisconsin, United States
photo
Ian Laquain
CO, KARIYA PHARMA
Kariya Pharmaceuticals
photo
Dr. Pauline Lau
CEO, SUNTEC MEDICAL, INC.
Suntec Medical, Inc.
Chino Hills, CA, California, United States
photo
Josh Lauer
GLOBAL HEAD OF PERSONALIZED HEALTHCARE MARKET DEVELOPMENT, ROCHE
The Secret Recipe to Maximizing Deals in Precision Medicine
photo
Vanina Laurent-Ledru
VP GLOBAL PUBLIC AFFAIRS , SANOFI
Diversity : A Business Imperative for the Life Sciences Industry
photo
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE (LHS)
How to Create Your Company Presentation in Just 15 Slides
photo
Dr. Mankit Law
SENIOR ASSOCIATE, PAPPAS CAPITAL
The Evolving Landscape of Venture Capital
Research Triangle Park, North Carolina, United States
photo
Mr. Chaim Lebovits
PRESIDENT AND CHIEF EXECUTIVE OFFICER, BRAINSTORM CELL THERAPEUTICS
Brainstorm Cell Therapeutics Inc.
New York, New York, United States
photo
Dr. Seth Lederman
CEO, TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Holding Corporation
New York, Nevada, United States
photo
Dr. Tae Gyu Lee
PRESIDENT, OSONG MEDICAL INNOVATION FOUNDATION, NEW DRUG DEVELOPMENT CENTER
Osong, South Korea - Global Innovation Hub
Cheongju, Korea - South Korea
photo
Young Sun Lee
VICE PRESIDENT OF BUSINESS DEVELOPMENT DIVISION (VPBD), YUNGJIN PHARM
Yungjin Pharm. Co., Ltd.
photo
Melanie Lee
CHIEF EXECUTIVE OFFICER, LIFEARC
Innovative Collaborations to Speed Science to Patients
photo
Dr. Antonio Lee
GLOBAL HEAD, BUSINESS DEVELOPMENT, MEDIPOST CO,. LTD.
MEDIPOST Co., Ltd.
Seoul, Korea - South Korea
photo
Dr. John Lee
CHIEF MEDICAL OFFICER, PHASEBIO PHARMACEUTICALS, INC.
PhaseBio Pharmaceuticals, Inc
Malvern, Pennsylvania, United States
photo
Bo Yeon Lee
SCIENTIFIC PROGRAM MANAGER, NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCE
Humans-in-a-Dish: Hope or Hype?
photo
Joseph Lehar
VICE PRESIDENT, DATA SCIENCES, ONCOLOGY, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
How Could AI Help Cure Cancer in the Next Five Years?
photo
Christoph Lengauer
PRESIDENT, CELSIUS
The Art & Science of R&D Innovation and Productivity
photo
Keith Leonard
CEO, UNITY BIOTECHNOLOGY
Anti-Aging Therapies: Taking Action to Increase the Human Healthspan
photo
Frank Leonard
SVP CORPORATE STRATEGY AND HEALTH POLICY, NOVOCURE
Blazing a Trail: Lessons on Bringing a New Technology to Market
photo
Mr. Mark Lesselroth
CEO, BIOPORTUSA
Demystifying US Market Entry - Global Innovation Hub
Syracuse, New York, United States
photo
Lizabeth Leveille, MS, MBA
ASSOCIATE VICE PRESIDENT AND HEAD, BOSTON INNOVATION HUB BUSINESS DEVELOPMENT & LICENSING, MERCK
How Early is Too Early? Valuing and De-Risking Preclinical Opportunities
Cambridge, Massachusetts, United States
photo
Roy Levien
CO-FOUNDER AND CHIEF DIGITAL OFFICER, EQUILITY
The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies
photo
Jeremy Levin
CEO, CHAIRMAN, OVID THERAPEUTICS
Fireside Chat with Jeffrey Solomon, Chief Executive Officer, COWEN
photo
Bruce Levine
BARBARA AND EDWARD NETTER PROFESSOR IN CANCER GENE THERAPY , UNIVERSITY OF PENNSYLVANIA
Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies
photo
Dr. Bruce Levine
BARBARA AND EDWARD NETTER PROFESSOR IN CANCER GENE THERAPY, IS THE DIRECTOR OF THE CLINICAL CELL AND, PENN MEDICINE
Gene Therapies : How to make disruptive innovation affordable for patients ?
Philadelphia, Pennsylvania, United States
photo
Noga Leviner
CO-FOUNDER & CHIEF EXECUTIVE OFFICER, PICNIC HEALTH
From Diagnostics to Treatment and Back Again in the Digital Era
photo
Freda Lewis-Hall
EXECUTIVE VICE PRESIDENT, CHIEF MEDICAL OFFICER, PFIZER
Innovative Collaborations to Speed Science to Patients
photo
Barbara Leyman
DIRECTOR, BUSINESS DEVELOPMENT, CALICO LIFE SCIENCES
Calico Life Sciences
South San Francisco, California, United States
photo
Ying Li
PARTNER, STEPTOE
Pitfalls for US Applicants When Filing Patent Applications at the EPO
photo
Ye Li
VICE PRESIDENT OF GOVERNMENT AFFAIRS AND POLICY, MERCK BIOPHARMA CHINA
China Summit Segment I: Opening Remarks / Key Regulatory and Policy Trends in Biopharmaceutical Innovation
photo
Mr. George Lin
CFO, HUA MEDICINE
Hua Medicine
Shanghai, China
photo
Stacy Lindley
VICE PRESIDENT AND HEAD OF EMERGING BIOPHARMA ALLIANCE MANAGEMENT , IQVIA
Biotech’s Contribution to Innovation: Current and Future Drivers of Success
photo
Ms. Kimberly Linthicum
SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, MYRIAD GENETICS
Precision Medicine and the FDA: Prospects for Regulation of Laboratory Developed Tests
Washington, District Of Columbia  , United States
photo
Evan Lippman
HEAD OF CORPORATE DEVELOPMENT AND BUSINESS DEVELOPMENT FINANCE, TAKEDA PHARMCEUTICALS
The New World of Life Sciences M&A Valuation: Strategies to Adapt and Thrive
photo
Dr. Benjamine Liu
CEO/CO-FOUNDER, TRIALSPARK
Disruptive Innovation in Clinical Trials: Tools to Accelerate Recruitment
New York, New York, United States
photo
Christopher Locher
CEO, VERSATOPE THERAPEUTICS
Versatope Therapeutics
Lowell, Massachusetts, United States
photo
Mr. Amir London
CEO, KAMADA
Kamada
Rehovot, Israel
photo
Bill Louv
PRESIDENT, PROJECT DATASPHERE
Considerations for Study Designs Incorporating External Data Sources to Augment or Generate Control Arm
photo
Lucie Low
SCIENTIFIC PROGRAM MANAGER, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (A BRANCH OF THE NIH)
Tissue Engineering Onboard the International Space Station